CA2446358C - Improved stent - Google Patents
Improved stent Download PDFInfo
- Publication number
- CA2446358C CA2446358C CA2446358A CA2446358A CA2446358C CA 2446358 C CA2446358 C CA 2446358C CA 2446358 A CA2446358 A CA 2446358A CA 2446358 A CA2446358 A CA 2446358A CA 2446358 C CA2446358 C CA 2446358C
- Authority
- CA
- Canada
- Prior art keywords
- stent
- troughs
- peaks
- circumferential
- circumferential bands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91516—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91566—Adjacent bands being connected to each other connected trough to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
A stent comprises a plurality of circumferential bands. Circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include peaks and troughs interconnected by bent struts.
The bands may overlap or may be connected by connectors.
The bands may overlap or may be connected by connectors.
Description
IMPROVED STENT
Background of Invention [0001] The use of stents in bodily lumen is well known. A stent is typically delivered in an unexpanded state to a desired location in a bodily lumen and then expanded.
The scent may be expanded via the use of mechanical device such as a balloon or the stent may be self-expanding.
Background of Invention [0001] The use of stents in bodily lumen is well known. A stent is typically delivered in an unexpanded state to a desired location in a bodily lumen and then expanded.
The scent may be expanded via the use of mechanical device such as a balloon or the stent may be self-expanding.
[0002] Because a stent often must be delivered through tortuous anatomy, it is desirable for the stent to be flexible. Increased flexibility in a stent, however, typically comes at the expense of scaffolding strength. Moreover, design features which may result in increased flexibility may also result in protruding edges which may damage vessels walls or catheter balloons during delivery of the stent through tortuous vasculature.
[0003] Many stents of conventional design include a plurality of serpentine bands which define openings in the sidewall of the stent. Typically, the openings are parallel to the longitudinal axis of the stent. Stents have been produced with openings which are oblique relative to the longitudinal axis of the stent. Stents where all of the openings are parallel to one another, however, may experience excessive torque upon delivery through tortuous vessels and resultant deployment problems.
[0004] There remains a need for a stent which has a high degree of flexibility in the unexpanded state, has adequate scaffolding strength and which does not experience excessive torque on delivery.
[0005]
[0006] Without limiting the scope of the invention, a brief summary of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below.
[0007] A brief abstract of the technical disclosure in the specification is provided as well.
Summary of Invention
Summary of Invention
[0008] In one embodiment, the invention is directed to a stent comprising a plurality of circumferential bands, circumferential bands which are adjacent one another connected one to the other, the stent including first circumferential bands characterized by a first number of alternating first peaks and first troughs joined by bent struts and second circumferential bands characterized by a second number of alternating second peaks and second troughs joined by bent struts, the second number different from the first number.
[0009] The first and second circumferential bands each define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of different lengths.
[0010] Desirably, the first and second peaks and first and second troughs are oriented at an angle between 00 and 70 with respect to the longitudinal axis of the stent. More desirably, the first and second peaks and first and second troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis of the stent and most desirably, the first and second peaks and first and second troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
[0011] Typically, the first and second circumferential bands may be characterized by a longitudinal extent with the longitudinal extent of each first circumferential band desirably exceeding the longitudinal extent of each second circumferential band.
[0012] Optionally, each of the bent struts may be characterized by a width with the width of the bent struts of the first bands exceeding the width of the bent struts of the second bands.
[0013] Desirably, bent struts which are circumferentially adjacent one another are parallel to one another. More desirably, bent struts in longitudinally adjacent first and second circumferential bands are non-parallel to one another.
[0014] In one embodiment of the invention, first and second circumferential bands which are longitudinally adjacent to one another are connected by at least one connector and desirably, by a plurality of connectors. Typically, the connectors will be straight and non-parallel to the longitudinal axis of the stent. Desirably, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. Also desirably, the connectors are shorter in length than the longitudinal extent of the second circumferential bands.
[001 5] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band. The first pathway is desirably of the same length as the second pathway.
[0016] In one embodiment, each first pathway traverses a total of three peaks and troughs (i.e. two peaks and one trough or one peak and two troughs) and each second pathway traverse a total of five peaks and troughs (i.e. three peaks and two troughs or two peaks and three troughs).
[001 7] In yet another embodiment, the invention is directed to a stent comprising a plurality of circumferential bands where circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands characterized by a first number of alternating first peaks and first troughs and second circumferential bands characterized by a second number of alternating second peaks and second troughs. The second number is different from the first number. The first peaks and troughs are oriented non-parallel to the longitudinal axis of the stent and the second peaks and second troughs are oriented non-parallel to the longitudinal axis of the stent.
Optionally, the first and second circumferential bands each define a pathway around the periphery of the stent and the first and second pathways are the same length.
[0018] Desirably, the peaks and troughs are oriented at an angle of at least degrees with respect to the longitudinal axis of the stent. More desirably, the peaks and troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
[0019] Desirably, the first and second circumferential bands are each characterized by a longitudinal extent with the longitudinal extent of the first circumferential bands exceeding the longitudinal extent of the second circumferential bands.
[0020] Also desirably, first peaks and first troughs which are circumferentially adjacent one another are connected by struts and second peaks and second troughs which are circumferentially adjacent one another are connected by struts. Each of the struts is characterized by a width. The width of the struts of the first bands exceeds the width of the struts of the second bands. Typically, struts which are circumferentially adjacent one another are parallel to one another.
[00211 First and second circumferential bands which are longitudinally adjacent one another may be connected by a single connector or by a plurality of connectors.
The connectors may be of any shape. In one embodiment, straight connectors are used. The connectors may be oriented parallel to the longitudinal axis or, in another embodiment, non-parallel to the longitudinal axis. Connectors with curved portions may also be used.
[0022] The connectors may extend from any region of one band to any region of an adjacent band. In one embodiment, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. In one desirable embodiment, first and second circumferential bands which are longitudinally adjacent one another are connected by a plurality of connectors and the connectors are shorter in length than the longitudinal extent of the second circumferential bands. Circumferentially adjacent connectors may be joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band with the first pathway being of the same length as the second pathway.
[0023] Desirably, the struts in first bands which are longitudinally adjacent one another are non-parallel to one another. More desirably, the struts in first bands which are longitudinally adjacent one another slant in opposing directions relative to the longitudinal axis of the stent.
[0024] In yet another embodiment of the invention, the first circumferential bands are connected to the second circumferential bands via straight connectors which extend between portions of similar curvature on adjacent circumferential bands. Desirably, the connectors extend between peaks of first circumferential bands and peaks of second circumferential bands and between troughs of second circumferential bands and troughs of first circumferential bands.
[0025] Typically, the connectors are shorter in length than the longitudinal extent L, of first circumferential bands.
[0026] In another embodiment, the invention is directed to a stent comprising a sidewall with a plurality of openings therein. Each opening is bounded by at least a first stent member and a second stent member. The first stent member is of a larger width than the second stent member. The first stent member comprises a plurality of bent first struts which extend non-parallel to the longitudinal axis of the stent and the second stent member comprises a plurality of bent second struts which extend non-parallel to the longitudinal axis of the stent. The bent first struts define finger like first projections which are non-parallel to the longitudinal axis of the stent and the bent second struts define finger like second projections which are non-parallel to the longitudinal axis of the stent with the number of second projections exceeding the number of first projections.
[0027] In one embodiment, each opening is defined by first projections which are non-parallel to the second projections.
[0028] In another embodiment, the openings comprise first openings and second openings, with each first opening defined by first projections which are parallel to the second projections. Typically each second opening is defined by first projections which are non-parallel to second projections.
[0029] In another embodiment, the invention is directed to a stent comprising a sidewall, the sidewall having a plurality of openings therein. Each opening is bounded by at least a first stent member and a second stent member. The first stent member is of a larger width than the second stent member. The first stent member comprises a plurality of bent first struts which extend non-parallel to the longitudinal axis of the stent and the second stent member comprises a plurality of bent second struts which extend non-parallel to the longitudinal axis of the stent.
The bent first struts define finger like first projections which are non-parallel to the longitudinal axis of the stent and the bent second struts define finger like second projections which are non-parallel to the longitudinal axis of the stent. The number of first projections exceeds the number of second projections.
[0030] In yet another embodiment, the invention is directed to a stent comprising a plurality of adjacent connected circumferential bands, including first circumferential bands characterized by a first number of alternating first peaks and first troughs joined by bent struts and second circumferential bands characterized by a second number of alternating second peaks and second troughs joined by bent struts where the second number is different from the first number. Each second circumferential band is connected to one adjacent first circumferential band via at least one connector which extends from a peak on the adjacent first circumferential band to a peak on the second circumferential band. Each second circumferential band is also connected to another adjacent first circumferential band via at least one connector which extends from a trough on the another first circumferential band to a trough on the second circumferential band.
[0031] The invention is also directed to a stent comprising a plurality of connected serpentine circumferential bands including a first serpentine circumferential band having a first total circumferential length at a proximal end of the stent, a second serpentine circumferential band having a second total circumferential length at a distal end of the stent and a third serpentine circumferential band having a third total circumferential length between the proximal and distal ends of the stent. The first and second total circumferential lengths differ from one another. Desirably, the first, second and third total circumferential lengths differ from one another. More desirably, the first and second total circumferential lengths are less than the third total circumferential length.
[0032] The invention is also directed to a stent comprising a plurality of connected serpentine circumferential bands. Each serpentine circumferential band comprises a plurality of peaks and troughs. Adjacent peaks and troughs are connected by bent struts. The serpentine circumferential bands include a first serpentine circumferential band having a first total circumferential length at a proximal end of the stent, a second serpentine circumferential band having a second total circumferential length at a distal end of the stent and a third serpentine circumferential band having a third total circumferential length between the proximal and distal ends of the stent. At least one of the first and second total circumferential lengths differs from the third total circumferential length. Desirably, the first, second and third total circumferential lengths differ from one another. More desirably, the first and second total circumferential lengths are less than the third total circumferential length.
[0033] The invention is also directed to a stent comprising a plurality of connected serpentine circumferential bands. Each serpentine circumferential band comprises a plurality of peaks and troughs with adjacent peaks and troughs connected by bent struts. Adjacent serpentine circumferential bands are connected one to the other in one or more regions of overlap where a peak in one serpentine band overlaps with a trough in an adjacent serpentine circumferential band.
The one or more regions of overlap extend in a longitudinal direction.
[0034] The invention is also directed to a stent comprising a plurality of connected serpentine circumferential bands. Each serpentine circumferential band comprises a plurality of peaks and troughs. Adjacent peaks and troughs are connected by nested bent struts. Serpentine circumferential bands which are adjacent one another are connected via a plurality of connections. The stent includes two serpentine circumferential bands which are connected via a first number of connections and two serpentine circumferential bands which are connected via a second number of connections, the second number different from the first number.
[0035] The invention is also directed to a stent comprising a plurality of adjacent serpentine circumferential bands containing alternating troughs and peaks.
Adjacent serpentine circumferential bands have a plurality of cells therebetween. At least two adjacent serpentine circumferential bands have a plurality of first cells therebetween and a plurality of second cells therebetween. The second cells are larger than the first cells.
[0036] The invention is also directed to a stent comprising a plurality of serpentine circumferential bands including a first serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by bent struts and a second serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by relatively straight struts. The first and second serpentine circumferential bands are connected to one another.
[0037] Without being bound by theory, bent struts have been found to provide more wall coverage than straight struts. Furthermore, using bent struts typically requires more material, i.e. metal, and thus provides improved radiopacity as well.
[0038] Additional details and/or embodiments of the invention are discussed below.
Brief Description of Drawings [0039] Fig. 1 a is a flat layout view of an inventive stent.
[0040] Fig. 1 b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 1 a.
[0041] Fig. 2a is a flat layout view of an embodiment of the inventive stent of the present invention which is similar to that shown in Fig. 1 a.
[0042] Fig. 2b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 2a.
[0043] Fig. 3a shows an alternative embodiment of the inventive stent of the present invention.
[0044] Fig. 3b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 3a.
[0045] Fig. 4a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0046] Fig. 4b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 4a.
[0047] Fig. 5a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0048] Fig. 5b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 5a.
[0049] Fig. 6a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0050] Fig. 6b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 6a.
[0051] Fig. 7a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0052] Fig. 7b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 7a.
[0053] Fig. 8a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0054] Fig. 8b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 8a.
[0055] Fig. 9a is a flat layout view of an inventive stent of the present invention.
[0056] Fig. 9b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 9a.
[0057] Fig. 10a is a flat layout view of an inventive stent of the present invention.
[0058] Fig. 10b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 10a.
[0059] Fig. 11 shows a flat layout view of an alternative embodiment of the inventive stent of the present invention.
[0060] Figs. 12-19 show flat layout views of other embodiments of the inventive stents of the present invention, the stents having large and small amplitude circumferential bands. Figs. 1 2a-1 9a show enlarged views of selected regions of the stents of Figs. 12-19.
[0061] Figs. 20-25 show flat layout views of other embodiments of the inventive stents of the present invention, the stents having circumferential bands of the same amplitude. Figs. 20a-25a show enlarged views of selected regions of the stents of Figs. 20-25.
[0062] Figs. 26-45 show flat layout views of other embodiments of the inventive stents of the present invention, the stents having overlapping circumferential bands.
Figs. 26a-45a show enlarged views of selected regions of the stents of Figs.
26-45.
[0063] Fig. 46 shows other connectors which may be used in the inventive stents.
Detailed Description [0064] While this invention may be embodied in many different forms, there are described in detail herein specific embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
[0065] For the purposes of this disclosure, like reference numerals in the figures shall refer to like features unless otherwise indicated.
[0066] Also for the purposes of this disclosure, the term 'bent strut' does not implicate a method of manufacture and is intended to include struts which have curves, struts which are angled, and struts which are curvilinear, regardless of how the struts or the stent as a whole are manufactured. Bent struts as referred to herein typically have two segments joined by a bent portion.
[0067] Finally, for the purposes of this disclosure, the expression 'total circumferential length' refers to the length of a circumferential band as the band is traversed about the circumference of the stent.
[0068] In one embodiment, the invention is directed to a stent such as that shown by way of example at 100 in Fig. 1 a comprising a plurality of circumferential bands. Circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 104 characterized by a first number of alternating first peaks 106 and first troughs 108 joined by bent struts 1 1 0 and second circumferential bands 1 12 characterized by a second number of alternating second peaks 114 and second troughs 1 16 joined by bent struts, 118. Typically, as shown in Fig. 1 a, the second number of second peaks and troughs is different from the first number of first peaks and troughs and desirably exceeds the first number.
[0069] The first and second circumferential bands each define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of different lengths. Desirably, the first and second pathways are the same length.
[0070] Also desirably, the first and second peaks and first and second troughs are oriented at an angle between 0 and 70 with respect to the longitudinal axis of the stent, more desirably they are oriented at an angle of at least 10 degrees with respect to the longitudinal axis of the stent, and most desirably, the first and second peaks and first and second troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
[00711 Typically, as shown in Fig. 1 b, the first and second circumferential bands may be characterized by longitudinal extents L, and L2. The longitudinal extent of each first circumferential band L, desirably exceeds the longitudinal extent L2 of the individual second circumferential bands.
[0072] Each of the bent struts may be characterized by a width. Optionally, the width of the bent struts of the first bands W, exceeds the width of the bent struts of the second bands W2-[0073] Desirably, as shown in Fig. 1 a, bent struts which are circumferentially adjacent one another are parallel to one another. More desirably, as shown in Fig.
1 a, bent struts in longitudinally adjacent first and second circumferential bands are non-parallel to one another.
[0074] In one embodiment of the invention, as shown in Fig. 1 a, first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 120 and desirably, by a plurality of connectors.
Typically, the connectors will be straight and non-parallel to the longitudinal axis 101 of the stent. In other embodiments of the invention, other types of connectors may be used for example connectors with one or more curves and/or connectors of different lengths. Desirably, as shown in Fig. 1 a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. Also desirably, as shown in Fig. I a, the connectors are shorter in length than the longitudinal extent L2 of the second circumferential bands.
[0075] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0076] In the embodiment of Fig. 1 a, each first pathway traverses a total of three peaks and troughs (i.e. two peaks and one trough or one peak and two troughs) and each second pathway traverse a total of five peaks and troughs (i.e. three peaks and two troughs or two peaks and three troughs).
[0077] In other words, between circumferentially adjacent connectors which connect first and second circumferential bands together, in the first band, there are a total of three peaks and troughs between the connectors, and in the second circumferential band there are a total of five peaks and troughs between connectors.
[0078] Without being bound by theory, the alternating orientation of adjacent first and second circumferential bands is believed to prevent significant rotation and build-up of torque and the accompanying degradation of stent performance.
[0079] In another embodiment, the invention is directed to a stent such as that shown by way of example at 100 in Fig. 2a comprising a plurality of circumferential bands substantially similar to those shown in Fig. 1 a. As in the embodiment shown in Fig. 1 a, the first and second circumferential bands each define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of different lengths. Desirably, the first and second pathways are the same length.
[0080] Also as in the embodiment shown in Fig. 1 a, the first circumferential bands 104 are characterized by a first number of alternating first peaks 106 and first troughs 108 joined by bent struts 1 1 0 and second circumferential bands 1 12 characterized by a second number of alternating second peaks 1 14 and second troughs 1 16 joined by bent struts, 118. Typically, as shown in Fig. 1 a, the second number of second peaks and troughs is different from the first number of first peaks and troughs and desirably exceeds the first number.
[0081] In the embodiment shown in Fig. 2a, however, in contrast to that shown in Fig. 1 a, the connectors do not extend between the nearest neighboring peaks and troughs, but rather every first peak of every first circumferential band 104 is connected to every third trough of a second adjacent circumferential band.
[0082] As in Fig. 1 b, the first and second circumferential bands may be characterized by longitudinal extents L, and L2 as shown in Fig. 2b. The longitudinal extent of each first circumferential band L, desirably exceeds the longitudinal extent L2 of the individual second circumferential bands.
[0083] Again as in Fig. 1 a, the first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 120 and desirably, by a plurality of connectors. Desirably, as shown in Fig. 2a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands as in Fig. 1 a. However, in the embodiment shown in Fig.
2a, the connectors are significantly longer in length than the longitudinal extent L2 of the second circumferential bands.
[0084] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0085] In the embodiment shown in Fig. 2a, each first pathway traverses a total of four peaks and troughs (i.e. two peaks and two troughs) and each second pathway traverse a total of six peaks and troughs (i.e. three peaks and three troughs).
[0086] In another embodiment, the invention is directed to a stent such as that shown by way of example at 300 in Fig. 3a comprising a plurality of circumferential bands. This embodiment is also similar to the embodiments shown in Fig. 1 a and 2a. Circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 304 characterized by a first number of alternating first peaks 306 and first troughs 308 joined by bent struts 310 and second circumferential bands 312 characterized by a second number of alternating second peaks 314 and second troughs 316 joined by bent struts. The number of second peaks and troughs is different from the number of first peaks and troughs and desirably exceeds the first number.
[0087] The first and second circumferential bands each define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of different lengths but are desirably the same length.
[0088] As shown in Fig. 3b, the first and second troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis 301 of the stent.
More desirably, the first and second peaks and first and second troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent. In the particular embodiment shown in Fig. 3b, the first and second peaks and first and second troughs, are actually oriented at an angle of about 40 degrees with respect to the longitudinal axis of the stent.
[0089] Typically, as shown in Fig. 3b, the first and second circumferential bands may be characterized by longitudinal lengths L, and Lz which may be of the same length, or of a different length. Desirably, L, exceeds the longitudinal extent L2 of the individual second circumferential bands.
[0090] Each of the bent struts may be characterized by a width. Optionally, the width of the bent struts of the first bands W, exceeds the width of the bent struts of the second bands W2.
[00911 The first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 320 and preferably by a plurality of connectors. In this particular embodiment, the connectors are straight, and are non-parallel to the longitudinal axis 301 of the stent 300. Also in the embodiment shown in Fig. 3a, the connectors are significantly shorter than the longitudinal extent of the circumferential bands L2. Other connectors may be optionally used, however including connectors having more curves or being of a different length.
[0092] In this embodiment, the connectors extend between peaks of circumferential bands to troughs of adjacent circumferential bands. In this particular embodiment, the connectors are shorter in length than the extent L2 of the second circumferential bands.
[0093] This may be optionally described in terms of first and second pathways.
Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0094] In the embodiment shown in Fig. 3a, the first pathway traverses a total of four peaks and troughs (two peaks and two troughs) and the second pathway traverses a total of six peaks and troughs (three peaks and three troughs).
[0095] Fig. 4a illustrates an embodiment similar to those shown in Figs. 1 a-3a as described above.
[0096] Again, there are first and second circumferential bands which define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of different lengths but are desirably the same length.
[0097] The first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 420 and preferably by a plurality of connectors. In this particular embodiment, the connectors are straight, and are non-parallel to the longitudinal axis 401 of the stent 400. Other connectors may be optionally used, however including connectors having more curves or being of a different length.
[0098] In this embodiment, the connectors extend between peaks of circumferential bands to troughs of adjacent circumferential bands. In this particular embodiment, the connectors are shorter in length than the extent L2 of the second circumferential bands.
[0099] This may be optionally described in terms of first and second pathways.
Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0100] Again, as in the embodiment shown in Fig. 3a, the embodiment shown in Fig. 4a includes a first pathway which traverses a total of four peaks and troughs (two peaks and two troughs) and the second pathway traverses a total of six peaks and troughs (three peaks and three troughs).
[0101 ] The connectors in the embodiment shown in Fig. 4a are at a different angle relative to the longitudinal axis 401 of stent 400 than those shown in Fig. 3a, the angle being smaller relative to the longitudinal axis in the embodiment shown in Fig. 4a.
[0102] An alternative embodiment of the inventive stent of the present invention is shown generally at 500 in Fig. 5a and again includes a plurality of circumferential bands. Circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 504 characterized by a first number of alternating first peaks 506 and first troughs 508 joined by bent struts 510 and second circumferential bands 512 characterized by a second number of alternating second peaks 514 and second troughs 516 joined by bent struts 518. In this particular embodiment, the number of second peaks and troughs is the same as the number of first peaks and troughs.
[0103] The first and second circumferential bands each define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of a different length. In the embodiment shown in Fig. 5a, the first and second pathways are of the same length.
[0104] The first and second peaks and first and second troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis 501 of the stent 500, and desirably are oriented at an angle of at least 15 degrees with respect to the longitudinal axis 501.
[0105] In this particular embodiment, as shown in Fig. 5b, the longitudinal extent L, of the first circumferential band is substantially equal in length to the longitudinal extent L2 of the second circumferential band.
[0106] Also in the embodiment shown in Fig. 5b, the width of each of the bent struts of the first bands W, is equal to the width of the bent struts of the second bands W2. Optionally, the widths may be different. For example, the width of the first bands W, may exceed the width of the second bands W2.
[0107] In the embodiment shown in Fig. 5a, first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 520 and desirably, by a plurality of connectors. Typically, in this embodiment, the connectors will be curved as opposed to the straight connectors as shown in some of the other embodiments. In this embodiment, the connectors extend from the troughs of circumferential bands to troughs of adjacent circumferential bands. The connectors are shown longer in length than the longitudinal extents L, and L2 of the circumferential bands.
[0108] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway. Each first pathway traverses a total of six peaks and troughs (three peaks and three troughs) and each second pathway traverses a total of six peaks and troughs (three peaks and three troughs).
[0109] In yet another alternative embodiment of the inventive stent of the present invention shown generally at 600 in Fig. 6a, the stent includes a plurality of circumferential bands wherein circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 604 characterized by a first number of alternating first peaks 606 and first troughs 608 and second circumferential bands 612 characterized by a second number of alternating second peaks 614 and second troughs 616. The second number is different from the first number. The first peaks and troughs are oriented non-parallel to the longitudinal axis 601 of the stent 600 and the second peaks and second troughs are oriented non-parallel to the longitudinal axis 601 of the stent. Desirably, the peaks and troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis of the stent. More desirably, the peaks and troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
[01101 The first and second circumferential bands each define a pathway around the periphery of the stent and the first and second pathways are the same length.
[01111 The stent is further characterized by bent struts which exhibit a configuration similar to finger-like projections. Each of the bent struts may be characterized by a width. Optionally, the width of the bent struts of the first bands W, exceeds the width of the bent struts of the second bands W2-[Oil 2] Desirably, as shown in Fig. 6a, bent struts which are circumferentially adjacent one another are parallel to one another. Bent struts in longitudinally adjacent first and second circumferential bands may or may not be parallel to one another, however.
[0113] In the embodiment shown in Fig. 6a, first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 620 and desirably, by a plurality of connectors. Typically, the connectors will be substantially straight and non-parallel to the longitudinal axis 601 of the stent. In other embodiments of the invention, other types of connectors may be used for example connectors with one or more curves and/or connectors of different lengths. Desirably, as shown in Fig. 6a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. Also desirably, as shown in Fig. 6a, the connectors are similar in length to the longitudinal extent L2 of the second circumferential bands.
[Oil 4] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[Oil 5] In the embodiment of Fig. 6a, each first pathway traverses a total of four peaks and troughs (i.e. two peaks and two troughs) and each second pathway traverse a total of six peaks and troughs (i.e. three peaks and three troughs).
[01 16] Yet another alternative embodiment of the inventive stent of the present invention is shown generally at 700 in Fig. 7a, the stent includes a plurality of circumferential bands wherein circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 704 characterized by a first number of alternating first peaks 706 and first troughs 708 and second circumferential bands 712 characterized by a second number of alternating second peaks 714 and second troughs 716. The second number is different from the first number. The first peaks and troughs are oriented non-parallel to the longitudinal axis 701 of the stent 700 and the second peaks and second troughs are oriented non-parallel to the longitudinal axis 701 of the stent. Desirably, the peaks and troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis of the stent. More desirably, the peaks and troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
[0117] The first and second circumferential bands each define a pathway around the periphery of the stent and the first and second pathways are the same length.
[0118] The stent is further characterized as having bent struts exhibiting finger-like projections which are similar to those in the embodiment shown in Fig.
6a. Each of the bent struts may be characterized by a width. Optionally, the width of the bent struts of the first bands W, exceeds the width of the bent struts of the second bands [Oil 91 Desirably, as shown in Fig. 7a, bent struts which are circumferentially adjacent one another are parallel to one another. Bent struts in longitudinally adjacent first and second circumferential bands may or may not be parallel to one another, however.
[0120] In the embodiment shown in Fig. 7a, first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 720 and desirably, by a plurality of connectors. Typically, the connectors are slightly curvilinear and are non-parallel to the longitudinal axis 701 of the stent.
In other embodiments of the invention, other types of connectors may be used for example connectors with one or more curves and/or connectors of different lengths.
Desirably, as shown in Fig. 7a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. Also desirably, as shown in Fig.
7a, the connectors are shorter in length than the longitudinal extent Li of the second circumferential bands.
[0121] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0122] In the embodiment of Fig. 7a, each first pathway traverses a total of four peaks and troughs (i.e. two peaks and two troughs) and each second pathway traverse a total of six peaks and troughs (i.e. three peaks and three troughs).
[0123] An alternative embodiment of the inventive stent of the present invention is shown in Fig. 8a. In this embodiment, the stent is substantially similar to that shown in Fig. 7a. The connectors 820 shown in the embodiment in Fig. 8a are straight while those shown in Fig. 7a are slightly curvilinear. The connectors 820 are again shorter in shorter in length than the longitudinal extent L2 of the second circumferential bands.
[0124] Again, a plurality of connectors are shown present and between adjacent first and second circumferential bands. The circumferentially adjacent connectors are again joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway. Again in the embodiment of Fig. 8a, each first pathway traverses a total of four peaks and troughs (i.e. two peaks and two troughs) and each second pathway traverse a total of six peaks and troughs (i.e.
three peaks and three troughs).
[0125] Desirably, as shown in Fig. 9b, the first and second circumferential bands 204 and 212 are each characterized by a longitudinal extent with the longitudinal extent L, of each the first circumferential bands exceeding the longitudinal extent L2 of the second circumferential bands.
[0126] In yet another embodiment, as shown generally at 200 in Fig. 9a, the invention is directed to a stent including a plurality of circumferential bands where circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 204 characterized by a first number of alternating first peaks 206 and first troughs 208 and second circumferential bands 212 characterized by a second number of alternating second peaks 214 and second troughs 216. The second number is different from the first number. The first peaks and troughs are oriented non-parallel to the longitudinal axis 201 of the stent and the second peaks and second troughs are oriented non-parallel to the longitudinal axis of the stent.
Desirably, the peaks and troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis of the stent. More desirably, the peaks and troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
Optionally, the first and second circumferential bands each define a pathway around the periphery of the stent and the first and second pathways are the same length.
[0127] Desirably, as shown in Fig. 9b, the first and second circumferential bands 204 and 212 are each characterized by a longitudinal extent with the longitudinal extent L, of each the first circumferential bands exceeding the longitudinal extent L2 of the second circumferential bands.
[0128] Also desirably, first peaks and first troughs which are circumferentially adjacent one another are connected by struts 21 8a and second peaks and second troughs which are circumferentially adjacent one another are connected by struts 21 8b. Each of the struts is characterized by a width with the width W, of the struts of the first circumferential bands exceeding the width W2 of the struts of the second circumferential bands.
[0129] Typically, as shown in Fig. 9a, struts which are circumferentially adjacent one another are parallel to one another.
[0130] First and second circumferential bands which are longitudinally adjacent one another may be connected by a single connector or by a plurality of connectors.
The connectors may be of any shape. In one embodiment, as shown in Fig. 9a, straight connectors 220 may be used. The connectors may be oriented non-parallel to the longitudinal axis, as shown in Fig. 9b or, in another embodiment, oriented parallel to the longitudinal axis.
[0131] The connectors may extend from any region of one circumferential band to any region of an adjacent circumferential band. In the embodiment of Fig.
9a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. In the embodiment of Fig. 9a, first and second circumferential bands 204 and 212 which are longitudinally adjacent one another are connected by a plurality of connectors 220 and the connectors are shorter in length than the longitudinal extent L2 of the second circumferential bands.
Circumferentially adjacent connectors may be joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band with the first pathway desirably being of the same length as the second pathway.
[0132] Desirably, as shown in Fig. 9a, the struts 21 8a in first circumferential bands which are longitudinally adjacent one, for example first circumferential bands 204a and 204b, are non-parallel to one another. More desirably, as shown in Fig 9a, the struts in first circumferential bands which are longitudinally adjacent one another slant in opposing directions relative to the longitudinal axis of the stent.
Without being bound by theory, the alternating orientation of adjacent first circumferential bands is believed to prevent significant rotation and build-up of torque and the accompanying degradation of stent performance.
[0133] In another embodiment of the invention, the first circumferential bands are connected to the second circumferential bands via straight connectors which extend between portions of similar curvature on adjacent circumferential bands. As shown by way of example in Fig. I Oa, connectors 220a extend between peaks 206 of first circumferential band 204a and peaks 214 of second circumferential band 212.
Connectors 220b extend between troughs 216 of second circumferential band 212 and troughs 208 of first circumferential bands 204b.
[0134] In the embodiment of Fig. 10a, connectors 220a and 220b are shorter in length than the longitudinal extent Li of first circumferential bands 204 but longer than the connectors of the embodiment of Fig. 1 Oa. In other embodiments of the invention, longer connectors may be used. Any of the other connectors disclosed herein may also be used to achieve different properties.
[0135] The invention is also directed to other embodiments in which the orientation of the struts in the first circumferential bands alternates between consecutive first circumferential bands relative to the longitudinal axis. In the embodiment of Fig. 11, the orientation of the struts in adjacent first circumferential bands 304a,b relative to the longitudinal axis alternates. Moreover, each second circumferential band 31 2a,b may comprise a plurality of consecutive struts 307' oriented in a first direction relative to the longitudinal axis of the stent and a plurality of consecutive struts 307" oriented in a second direction opposite the first direction and relative to the longitudinal axis of the stent. Adjacent circumferential bands are connected via connectors 329. Desirably, in the embodiment of Fig.
11, the connectors are oriented longitudinally. Any of the other connectors disclosed herein may be used to achieve stents with other characteristics.
[0136] First circumferential bands 304a,b may be longer or the same length about the periphery of the stent as second circumferential bands 31 2a,b.
First circumferential bands 304a,b are desirably wider than second circumferential bands 31 2a,b. Also desirably, the first circumferential bands have fewer peaks and troughs than the second circumferential bands.
[0137] It is further within the scope of the invention to vary the number of connectors extending between adjacent circumferential bands in any of the embodiments disclosed herein. For example, adjacent circumferential bands in the middle of the stent may be joined by more connectors than adjacent circumferential bands at the proximal and/or distal ends of the stent so that the proximal and/or distal ends of the stent are more flexible. The middle portion of the stent may have fewer connectors than the proximal and/or distal ends of the stent to achieve greater flexibility in the middle of the stent than in the proximal and/or distal ends of the stent. The number of connectors may increase over the length of the stent to provide a stent with increasing rigidity over its length.
[0138] The invention is also directed to a stent such as that shown by way of example in Fig. 1 a, comprising a sidewall with a plurality of openings 122 therein.
Each opening is bounded by at least a first stent member and a second stent member. The first stent member 134 (shown shaded) is of a larger width than the second stent member 142 (shown shaded). The first stent member 134 comprises a plurality of bent first struts 110 which extend non-parallel to the longitudinal axis 101 of the stent and the second stent member 142 comprises a plurality of bent second struts 1 18 which extend non-parallel to the longitudinal axis of the stent.
The bent first struts define finger like first projections 124 (shown shaded) which are non-parallel to the longitudinal axis of the stent and the bent second struts define finger like second projections 126 which are non-parallel to the longitudinal axis of the stent with the number of first projections exceeding the number of second projections.
[0139] Desirably, as shown in the embodiment of Fig. 1 a, each opening is defined by first projections which are non-parallel to second projections.
[0140] In another embodiment, as shown by way of example in Fig. 9a, the stent comprises a plurality of openings including first openings 222a and second openings 222b. Each first opening 222a includes first projections 224a which are parallel to second projections 226a. Each second opening 222b includes first projections 224b which are non-parallel to second projections 226b.
[01411 The stent of Fig. 9a also has first openings and second openings where each first opening includes first projections which are parallel to second projections.
Each second opening includes first projections which are non-parallel to second projections.
[0142] In another embodiment, the invention is directed to a stent such as that shown at 100 in Fig. 12 comprising a plurality of circumferential bands.
Circumferential bands which are adjacent one another are connected one to the other. At least a portion of the stent, and, desirably, as shown in Fig. 12, the entirety of the stent consists of first circumferential bands 104 characterized by a first number of alternating first peaks 106 and first troughs 108 joined by bent struts 1 1 0 and second circumferential bands 1 12 characterized by a second number of alternating second peaks 114 and second troughs 1 16 joined by bent struts 118.
Typically, as shown in Fig. 12, the second number of second peaks and troughs is different from the first number of first peaks and troughs and desirably exceeds the first number. First circumferential bands which are adjacent to second circumferential bands are connected thereto by at least one, and desirably, as shown in Fig. 12, a plurality of connectors 120. Connectors 120 extend from troughs of first circumferential bands to troughs of second circumferential bands and from peaks of second circumferential bands to peaks of first circumferential bands.
Connectors 120 are bent and are generally parallel to the struts of the first circumferential bands.
[0143] In the embodiment of Fig. 12, with the exception of the connectors of the end bands, each connector which extends in distal direction is separated by one struts 11 Ofrom a connector extending in a distal direction.
[0144] In the embodiment of Fig. 13, adjacent first circumferential bands 104 and second circumferential bands 1 12 are connected to one another via one and desirably a plurality of connectors 120 which extend from peaks 106 of first circumferential bands to troughs 116 of second circumferential bands 112 and from peaks 1 1 4 of second circumferential bands 1 12 to troughs 108 of first circumferential bands 104. Connectors 120 are desirably significantly shorter than the struts of the second circumferential band 112. More desirably, the length of connectors 120 is on the order of magnitude of the width of the struts 110 of first circumferential band 104. As shown in Fig. 13, each connector which extends in a distal direction is separated from a connector extending in a proximal direction by three struts. Connectors 120 are straight and oriented parallel to the longitudinal axis.
[0145] In the embodiment of Fig. 13, as well as in many of the other embodiments of the invention, connectors 120 do not extend from the center of the peaks and troughs but rather extend from corners of the peaks and troughs. In the embodiment of Fig. 12, connectors extend from the center of the peaks and troughs.
[0146] The individual sections 1 10a and 1 10b of bent struts 1 10 of the inventive stent of Fig. 13 extend at a more gradual angle relative to the longitudinal axis of the stent than the individual sections of the bent struts of the stent of Fig.
12.
Specifically, the sections of the bent struts of the stent of Fig. 12 extend at a 40 degree angle relative to the longitudinal axis and the sections of the bent struts of the stent of Fig. 13 extend at a 30 degree angle relative to the longitudinal axis.
[0147] Depending on the alignment of adjacent circumferential bands, the connectors may also be at an angle relative to the longitudinal axis as shown in Fig.
14. Connectors 120 are non-parallel to the longitudinal axis, extending at an oblique angle relative to the longitudinal axis. In the stent of Fig. 14, the orientation of connectors relative to the longitudinal axis reverses along the length of the stent with connectors 1 20a extending in a first direction and connectors 120b extending in a second opposite direction relative to the longitudinal axis of the stent.
[0148] In the embodiment of Fig. 1 5, the sections 1 10a and 1 10b of the bent struts 1 10 extend at a 40 degree angle relative to the longitudinal axis of the stent.
Straight connectors 120 are provided between adjacent circumferential bands and 112.
[0149] In the embodiment of Fig. 16, adjacent first and second circumferential bands 104 and 1 12 are spaced further apart from one another than in some of the previous embodiments. As a result, connectors 120 are longer than in other embodiment where the connectors extend between peaks and troughs. Also, the bent struts 1 10 of the first circumferential bands 104 are much closer in width to the bent struts 1 10 of the second circumferential bands 112.
[01 50] Fig. 17 is an embodiment with narrower bent struts in the first circumferential bands and with connectors 120 which are parallel to the longitudinal axis of the stent.
[01511 The embodiment of Fig. 18 is similar to that of Fig. 17, differing in part in that the sections of the bent struts extend at a 40 degree angle relative to the longitudinal axis rather than the 30 degree angle of the struts of Fig. 17.
[0152] The stent of Fig. 19 comprises first circumferential bands 104 which have bent struts 1 1 0 and second circumferential bands 1 12 which have relatively straight struts which are not parallel to the longitudinal axis of the stent. The orientation of the struts of the second circumferential bands reverses along the length of the stent.
Connectors 120 extend from peaks 106 of first circumferential bands 104 to peaks 114 of second circumferential bands 1 12 and from troughs 116 of second circumferential bands 1 12 to troughs 108 of first circumferential bands 104.
[01 53] In the embodiment of Fig. 20, adjacent circumferential bands 104 are of the same longitudinal extent and have an identical number of peaks 106 and an identical number of troughs 108. Connectors 120 extend from peaks 106 of circumferential bands 104 to troughs 108 of adjacent circumferential bands 104 and from troughs 106 of circumferential bands 104 to peaks 106 of adjacent circumferential bands 104. The connectors 120 are parallel to the longitudinal axis of the stent.
[01 54] In the embodiment of Fig. 26, adjacent circumferential bands 104 share one or more members 130 in common. One or more peaks 106a of one circumferential band 104 are longer than the remaining peaks 1 06b and one or more troughs 1 08a of the adjacent circumferential band 104 are longer than the remaining troughs 1 08b. The longer peaks 1 06a intersect with the longer troughs 1 08a and share a member 130 in common forming an H-shaped structure 132. The resulting H-shaped structure in the embodiment of Fig. 26 is oriented at an oblique angle relative to the longitudinal axis of the stent with the cross-bar portion 130 of the 'H' shaped structure extending in a circumferential direction. In other embodiments of the invention, cross-bar portion 130 of the H-shaped member is oriented in a longitudinal direction, as shown for example in Fig. 30, or in a circumferential direction, as shown for example, in Fig. 31.
[01 55] In the embodiment of Fig. 26, there are three overlapping regions 130 between adjacent circumferential bands 104. The distal end of each cell 136 is defined by two full peaks 106 and two full troughs 108 and the proximal end of each cell 136 is defined by two full peaks 106 and two full cells 136. It is also within the scope of the invention for there to be fewer overlapping regions 130 between adjacent circumferential bands 104 or more overlapping regions 130 between adjacent circumferential bands 104. In the embodiment of Fig. 27, there are four overlapping regions 130 between adjacent circumferential bands 104. The distal end of each cell 136 is defined by three full peaks 106 and three full troughs and the proximal end of each cell 136 is defined by three full peaks 106 and three full troughs 136. The 'H' shaped structures 132 extend in an oblique direction relative to the longitudinal axis of the stent.
[0156] In the stents of Figs. 26-37 it is also noted that the total circumferential length of the proximal and distal most circumferential bands 1 04a is less than the total circumferential length of the other circumferential bands 1 04b.
Desirably, the difference in total circumferential length is on the order of 5%. In another embodiment of the invention, the proximal and distal most circumferential bands are of the same total circumferential length as the other circumferential bands.
In another embodiment of the invention, the proximal and distal most circumferential bands are of greater total circumferential length than the other circumferential bands. In yet another embodiment of the invention only of the proximal and distal most circumferential bands are of greater total circumferential length than the other circumferential bands. In yet another embodiment of the invention only of the proximal and distal most circumferential bands are of lesser total circumferential length than the other circumferential bands. Finally, in yet another embodiment of the invention one of the proximal and distal most circumferential bands is of greater total circumferential length than the other circumferential bands and the other of the proximal and distal most circumferential bands is of lesser total circumferential length than the other circumferential bands.
[015 71 In the stents of Figs. 43-45, the proximal-most and distal-most circumferential bands 1 04a,c are of different total circumferential lengths than the remainder of the circumferential bands 1 04b. In this case, they are shorter than the other circumferential bands 104b. Moreover, the proximal-most bands 1 04a are of shorter total length than the distal-most circumferential band 1 04c. In the stents of Figs. 43-45, adjacent circumferential bands 104 have regions 130 of overlap.
More generally, the invention is directed to stents comprising circumferential bands wherein the proximal-most and distal-most circumferential bands are of less total circumferential length than the remainder of the circumferential bands and one of the proximal-most and distal-most circumferential bands is shorter than the other.
The circumferential bands may overlap one another or may be connected by connecting which extend through gaps separating adjacent circumferential bands.
[0158] The stents of Figs. 43-45 is also notable in that the number of overlapping regions 130 alternates between 2 and 3 along the length of the stent.
This results in alternating regions having three cells 136 extending about the circumference of the stent and regions having two cells 136 extending about the circumference of the stent. More generally, the invention is directed to stents having alternating numbers of overlapping regions or connections between adjacent bands along the length of the stent. Thus, the number of overlapping regions or connections between adjacent bands will alternate between N and M where N and M
are different integers greater than or equal to 1. The invention is also directed to stents having alternating numbers of cells in circumferential bands along the length of the stent. Thus, the number of cells arranged about the circumference of the stent will alternate between N and M along the length of the stent where N and M are different integers greater than or equal to 1.
[0159] The stents of Figs. 43-45 also have more cells disposed about the circumference at one end than at the other end.
[0160] The invention is also direct to a stent such as that shown by way of example in Fig. 12, comprising a plurality of circumferential bands, with adjacent circumferential bands connected one to the other via a plurality of connectors. The circumferential bands include first circumferential bands 104 characterized by a first number of alternating first peaks 106 and first troughs 108 joined by bent struts 110 and second circumferential bands 112 characterized by a second number of alternating second peaks 114 and second troughs 1 16 joined by bent struts 118.
The second number is different from the first number. Each second circumferential band 1 12 is connected to one adjacent first circumferential band 104 via at least one connector 120 and desirably a plurality of connectors 120. The one or more connectors 120 extend from peaks 106 on the adjacent first circumferential band 104 to peaks 1 14 on the second circumferential band 112. Each second circumferential band 1 12 is also connected to another adjacent first circumferential band 104 via one or more connectors 120 extending from troughs 108 on the another first circumferential band 104 to troughs 1 16 on the second circumferential band 112.
[01611 Desirably, the connectors 120 are not straight. More desirably, as shown in Fig. 12, the connectors 120 are substantially parallel to the bent struts 110 of the first circumferential bands 104.
[0162] In the embodiment of Fig. 12, the first and second circumferential bands are each characterized by a longitudinal extent and the longitudinal extent of each first circumferential band 104 exceeds the longitudinal extent of each second circumferential band 112. It is also within the scope of the invention for the first and second circumferential bands to be of the same longitudinal extent.
[0163] Also, in the embodiment of Fig. 12, the first circumferential bands 104 are each characterized by a first total circumferential length and the second circumferential bands 1 12 are each characterized by a second total circumferential length and the first total circumferential length is equal to the second total circumferential length. In other embodiments of the invention, the first and second circumferential bands may be of different total circumferential lengths.
[0164] The invention is also directed to a stent, such as that shown by way of example in Fig. 43, comprising a plurality of serpentine circumferential bands 104.
Adjacent serpentine circumferential bands 104 are connected one to the other.
The serpentine circumferential bands 104 include a first serpentine circumferential band 1 04a having a first total circumferential length at a proximal end of the stent, a second serpentine circumferential band 1 04b having a second total circumferential length at a distal end of the stent and a third serpentine circumferential band 1 04c having a third total circumferential length between the proximal and distal ends of the stent. The first and second total circumferential lengths differ from one another.
Desirably, the first, second and third total circumferential lengths differ from one another. More desirably, the first and second total circumferential lengths are less than the third total circumferential length.
[0165] As shown in Fig. 43, the serpentine circumferential bands include a band 1 04a of a first longitudinal extent and a band 104b of a second longitudinal extent different from, and desirably, less than the first longitudinal extent. The first longitudinal extent is greater than the second longitudinal extent.
[0166] The stent may optionally have serpentine circumferential bands having a first number of peaks and troughs and serpentine circumferential bands having a second number of peaks and troughs, the second number less than the first number, as shown for example in Fig. 12.
[0167] Desirably, as shown in Fig. 43, each serpentine circumferential band 104a-c comprises a plurality of peaks 106 and troughs 108 with bent struts 1 extending between adjacent peaks 106 and troughs 108. Circumferentially adjacent bent struts 1 10 are nested as they are in many other embodiments disclosed herein.
[0168] The invention is also directed to a stent such as that shown by way of example in Fig. 43, comprising a plurality of interconnected serpentine circumferential bands 1 04a-c, each comprising a plurality of peaks 106 and troughs 108. Adjacent peaks 106 and troughs 108 are connected by bent struts 110. The bent struts 110 are arranged in a nested relationship. The serpentine circumferential bands 104 include a first serpentine circumferential band 1 04a having a first total circumferential length at a proximal end of the stent, a second serpentine circumferential band 104b having a second total circumferential length at a distal end of the stent and a third serpentine circumferential band 1 04c having a third total circumferential length between the proximal and distal ends of the stent.
At least one of the first and second total circumferential lengths differs from the third total circumferential length.
[0169] Desirably, as shown in Fig. 43, both the first and second total circumferential lengths differ from the third total circumferential length.
More desirably, at least one of the first and second total circumferential lengths is less than the third total circumferential length.
[01701 Adjacent serpentine circumferential bands may be connected by connectors extending from peaks to troughs, where the connectors are shorter in length than the bent struts. In the embodiment of Fig. 43, some of the peaks 106a and troughs 108a of adjacent serpentine circumferential bands 104 overlap one another and are joined one to the other. The overlapping peaks 1 06a and troughs 108a are longer than the remaining peaks 106 and troughs 108. The regions 130 of overlap between adjacent bands extend in a direction oblique to the longitudinal axis of the stent. The region may also extend in a circumferential direction or in a longitudinal direction. Examples of overlap regions 130 extending in these directions are shown in Figs. 30 and 38.
[01711 The invention is also directed to a stent such as that shown in Fig.
30, comprising a plurality of serpentine circumferential bands 104. Each serpentine circumferential band 104 comprises a plurality of peaks 106 and troughs 108 which are connected by bent struts 110. Adjacent serpentine circumferential bands are connected one to the other in one or more regions 130 of overlap where a peak 1 06a in one serpentine band overlaps with a trough 1 08a in an adjacent serpentine circumferential band. The one or more regions 130 of overlap extending in a longitudinal direction.
[0172] Optionally, at least one serpentine circumferential bands 104 will be of a greater total circumferential length than other of the serpentine circumferential bands 104. In the embodiment of Fig. 30, the proximal-most and distal-most serpentine circumferential bands 1 04a are of shorter total circumferential length than the remaining serpentine circumferential bands 104b of the stent.
[0173] The invention is also directed to a stent, as shown by way of example in Fig. 37, comprising a plurality of serpentine circumferential bands 104 where each serpentine circumferential band 104 comprises a plurality of peaks 106 and troughs 108. Adjacent peaks 106 and troughs 108 are connected by nested bent struts 110.
Serpentine circumferential bands 104 which are adjacent one another are connected via a plurality of connections 130. The stent includes two serpentine circumferential bands which are connected via a first number of connections and two serpentine circumferential bands which are connected via a second number of connections, where the second number is different from the first number.
[0174] The connections may be in the form of overlapping regions 130 of peaks 106a and troughs 108a on adjacent serpentine circumferential bands 104 or may be form of linear segments extending from one serpentine circumferential band to another serpentine circumferential band. An example of the latter connectors is shown in Fig. 25.
[01 75] Typically, the stent will have twice as many of the first number of connections as compared to the second number of connections. In the embodiment of Fig. 37, six connections are provided between the proximal-most serpentine circumferential band 104a and the serpentine circumferential band 1 04b adjacent thereto and six connections are provided between the distal-most serpentine circumferential band 104c and the serpentine circumferential band 1 04b adjacent thereto. The remainder of the adjacent serpentine circumferential bands 104b have three connections. Other numbers of connections are also within the scope of the invention. By way of example, the proximal-most serpentine circumferential band and the serpentine circumferential band adjacent thereto and/or the distal-most serpentine circumferential band and the serpentine circumferential band adjacent thereto may have four five, six or more connections and the remainder of the serpentine circumferential bands may have three connections.
[0176] The stents may optionally be constructed such that at least one of the proximal-most serpentine circumferential band and the distal-most serpentine circumferential band is of a different total circumferential length than other of the serpentine circumferential bands. Typically, the proximal-most and/or distal-most serpentine circumferential bands will be shorter in total circumferential length than the remaining bands. Moreover, the proximal-most serpentine circumferential band may be of a different total length than the distal-most serpentine circumferential band.
[0177] The invention is also directed to a stent such as that shown by way of example in Fig. 37 comprising a plurality of adjacent serpentine circumferential bands 104 containing alternating troughs 108 and peaks 106. Adjacent serpentine circumferential bands 104 have a plurality of cells 136 therebetween. At least two adjacent serpentine circumferential bands 104 have a plurality of first cells 1 36a therebetween and a plurality of second cells 136b therebetween. The second cells 1 36b are larger than the first cells 1 36a. Desirably the first and second cells 1 36a,b alternate with one another about the circumference of the stent. Optionally, as shown in Fig. 37, at least two adjacent serpentine circumferential bands 104 at the proximal end of the stent have a plurality of first cells 136a therebetween and a plurality of second cells 1 36b therebetween, the second cells 1 36b larger than the first cells 1 36a and at least two adjacent serpentine circumferential bands 104 at the distal end of the stent have a plurality of first cells 1 36a therebetween and a plurality of second cells 136b therebetween, the second cells 1 36b larger than the first cells 136a. Desirably, the second cells 1 36b are at least approximately twice the area of the first cells 1 36a. In the embodiment of Fig. 37, the first cells 1 36a are bounded at one end by one peak 106 and at another end by one trough 108.
[0178] In some embodiments of the invention, circumferentially adjacent struts are not parallel to one another. In the embodiments of Fig. 40 and 43, for example, as shown in inset A, bent struts 1 10 comprise first region 1 10a and second region 1 10b joined by elbow 1 10c. First region 1 10a is longer than second region 1 10b.
Each first region 1 10a is at an angle a (or 180 - a depending on whether first region inclines toward the distal end of the stent or declines toward the distal end of the stent) relative to the longitudinal axis of stent and each second second region 1 10b is at an angle 0 relative to the longitudinal axis of the stent (or 180 - P
depending on whether the second region declines toward the distal end of the stent or inclines toward the distal end of the stent). Elbow 1 10c subtends an angle y given by a - 0. Desirably, a and R are chosen such that elbow 1 10c subtends an angle y between about 5 degrees and 90 degrees.
[01 79] Each peak 104 of the stent has a first region 1 10a of one bent strut and a second region 1 10b of a second bent strut extending therefrom. First region 1 10a and second region 1 10b extending from the peak are non-parallel to one another.
Each trough 106 of the stent has a first region 1 10a of one bent strut and a second region 1 10b of a second bent strut extending therefrom. First region 1 10a and second region 1 10b extending from the trough are non-parallel to one another as well.
[0180] Because of the difference in length of the first and second regions and the angles of the first and second regions, adjacent inflection points 1 10d of elbows 1 10c on a given circumferential band are staggered slightly in a longitudinal direction as the circumference of the stent is traversed.
[01811 These features allow for improved crimpability of the stent.
[0182] Desirably, the angle y of the elbow regions of the inventive stents remains constant on expansion of the stent and is substantially the same in the expanded state as it is in the unexpanded state. This feature contributes to compression resistance of the stent.
[0183] The invention is also directed to a stent comprising a plurality of serpentine circumferential bands including a first serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by bent struts and a second serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by relatively straight struts. The first and second serpentine circumferential bands are connected to one another. Desirably, the first and second serpentine circumferential bands are connected one to the other via a plurality of connectors which optionally are straight and optionally non-parallel to the longitudinal axis of the stent. Typically, the connectors will extend from peaks on the first serpentine circumferential bands to peaks on the second serpentine circumferential band.
[0184] An example of such a stent is shown at 100 in Fig. 19. The stent of Fig.
19 comprises a plurality of the first serpentine circumferential bands and a plurality of the second serpentine circumferential bands where serpentine circumferential bands which are adjacent one another are connected one to the other. In the stent of Fig. 19. the first and second serpentine circumferential bands alternate with one another over the length of the stent.
[0185] Any of the inventive stents disclosed above may be provided with a uniform diameter or may taper in portions or along the entire length of the stent.
Also, the width and/or thickness of the various portions of the inventive stents may increase or decrease along a given portion of the stent. For example, the width and/or thickness of the circumferential bands and/or connectors may increase or decrease along portions of the stent or along the entire length of the stent.
The amplitude and wavelength of several successive first circumferential bands may remain constant while the width and/or thickness of the successive first circumferential bands decrease. Similarly, the amplitude and wavelength of several successive second circumferential bands may remain constant while the width and/or thickness of the successive second circumferential bands decrease.
[0186] The inventive stents may also be provided with end effects by modifying the stent such that that one or both ends are more rigid or more flexible than the remainder of the stent. Any of the inventive stents disclosed herein may be modified to have proximal-most and/or distal-most circumferential bands of a greater total circumferential length than the remaining circumferential bands. Any of the inventive stents disclosed herein may also be modified to have proximal-most and/or distal-most circumferential bands of a lesser total circumferential length than the remaining circumferential bands. Moreover, any of the inventive stents disclosed herein may also be modified so that one of the ends has circumferential bands of a lesser total circumferential length than the circumferential band of the other end which in turn is longer or shorter than the total length of any of the remaining circumferential bands.
[0187] Also, one or both of the end circumferential bands may be modified to be of a greater longitudinal extent than the remaining circumferential bands or to be of a lesser longitudinal extent than the remaining circumferential bands. Each of the two end circumferential bands may differ in longitudinal extent with one another and with the remaining circumferential bands.
[0188] The invention also contemplates modifying the ends of any of the inventive stents so that the two proximal-most and/or two distal-most circumferential bands have more connections therebetween than the remaining circumferential bands or fewer connections therebetween than the remaining circumferential bands.
[0189] Further, the proximal-most and/or distal-most circumferential bands may be of a greater mass than the remaining bands or a lower mass than the remaining bands. They may be thicker than the remaining bands or thinner than the remaining bands.
[0190] It is understood that the above discussed modifications resulting in end effects may be applied to multiple circumferential bands at one or both ends of the stent and are not limited to the proximal-most and distal-most circumferential bands.
[01911 The stents disclosed herein may also be modified by employing different types of connections between the circumferential bands. To that end, any of the connectors and connector configurations disclosed herein may be used in any of the disclosed embodiments. For example, in those embodiments in which adjacent circumferential bands overlap, the stent may be modified so that the adjacent circumferential bands do not overlap and are connected by connectors extending between the circumferential bands. Any of the connectors and connector configurations may be used. Other shaped connectors may also be used including those shown at 1 20a-i in Fig. 46. As shown in Fig. 46, the connectors may have one or more bends therein. The connectors may extend from peaks to troughs, from peaks to peaks, from troughs to peaks and/or from troughs to troughs. The connectors may be longer than the individual circumferential bands, which may, but need to occur with connectors with bends therein or they may be shorter than the individual segments.
[0192] The stents disclosed herein may also be modified by changing the number of connections between adjacent circumferential bands. Thus, where larger cells are desired, fewer connections between circumferential bands will be provided.
Where smaller cells are desired, more connections between bands will be provided.
Any of the embodiments shown may also be modified in some portions of the stent but not others. Thus, some sections of the stent may have more connections and other sections may have fewer connections. More flexibility may be achieved by providing fewer connections between adjacent circumferential bands.
[0193] The connectors may range in width from being wider than the width of the widest struts in the stent, to being narrower than the narrowest struts in the stent or anywhere in between. Regions of different flexibility may also be achieved by using wider connection in some regions, for example the one or both of the ends of the stent and narrower connectors in the other regions of the stent (e.g.
the middle) or vice versa.
[0194] The invention also contemplates embodiments in which the spacing between adjacent circumferential bands varies in different portions of the stent. For example, the proximal-most circumferential band and/or the distal-most circumferential band may be spaced further apart from the circumferential bands adjacent thereto or may be spaced closer thereto. This would result in using longer connectors between the end bands or shorter connectors, depending on the configuration. In one embodiment, both the proximal-most and the distal-most circumferential bands are more closely spaced to adjacent circumferential bands than the spacing between the remaining circumferential bands and further, the spacing between the proximal-most circumferential band and the circumferential band adjacent thereto differs from the spacing between the distal-most circumferential band and the circumferential band adjacent thereto.
[0195] It is also within the scope of the invention for any of the stent disclosed herein to have connectors extending from regions other than peaks and trough or corners of peaks and troughs. For example, the connectors may extend from positions midway between adjacent peaks and troughs, from position one quarter of the way between peaks and troughs, from positions three quarters of the way between peaks and troughs or anywhere else between peaks and troughs.
[0196] As shown in the various embodiments, the connections between circumferential bands may extend in a longitudinal direction or may have first and second ends which are circumferentially and longitudinally offset from one another, as in the case of connections extending at an oblique angle. The connections may also include portions which are non-parallel to the longitudinal axis of the stent.
[0197] The 'phase relationship' between adjacent circumferential bands may also be modified in any of the embodiments. For example, in embodiments of the invention such as that of Fig. 24, peaks of adjacent cylindrical bands may be in longitudinal alignment with one another or may be unaligned with one another in the longitudinal direction. Similarly, peaks on one band may be longitudinally aligned with troughs on an adjacent circumferential band or may be unaligned with troughs on an adjacent circumferential band. Some of the adjacent circumferential bands may be aligned while other adjacent bands may not be aligned.
[0198] Bent struts as referred to herein typically have two segments joined by a bent portion. The segments are straight as shown in the figures but may also be curved, The bent struts may be modified to have more than one bend. For example, a strut having three or more segments and two or more bends may also be used.
More generally, substantially bow shaped struts may be used.
[0199] The stent patterns disclosed herein may also be used for bifurcated stents. One or more legs and/or the trunk of a bifurcated stent may be provided with any of the stent designs disclosed herein.
[0200] The inventive stents may be manufactured using known stent manufacturing techniques. Suitable methods for manufacturing the inventive stents include laser cutting, chemical etching or stamping of a tube. The inventive stents may also be manufactured by laser cutting, chemically etching, stamping a flat sheet, rolling the sheet and, optionally, welding the sheet. Other suitable manufacturing techniques include electrode discharge machining or molding the stent with the desired design. The stent may also be manufactured by welding individual sections, for example, circumferential bands, together. Any other suitable stent manufacturing process may also be used.
[0201] Any suitable stent material may be used in the manufacture of the inventive stents. Examples of such materials include polymeric materials, metals, ceramics and composites. Suitable polymeric materials include thermotropic liquid crystal polymers (LCP's). Where the stent is made of metal, the metal may be stainless steel, cobalt chrome alloys such as elgiloy, tantalum or other plastically deformable metals. Other suitable metals include shape-memory metals such as nickel-titanium alloys generically known as "nitinol", platinum/tungsten alloys and titanium alloys.
[0202] The invention also contemplates the use of more than one material in the inventive stents. For example, the first undulating bands and the second undulating bands may be made of different materials. Optionally, the connectors may be made of a different material than the first and/or second undulating bands.
[0203] The inventive stents may be provided in mechanically expandable form, in self-expanding form or as a hybrid of the two. Mechanically expandable stents, in accordance with the invention, may be expanded using any suitable mechanical device including a balloon.
[0204] The inventive stents may include suitable radiopaque coatings. For example, the stents may be coated with gold or other noble metals or sputtered with tantalum or other metals. The stents may also be made directly from a radiopaque material to obviate the need for a radiopaque coating or may be made of a material having a radiopaque inner core. Other radiopaque metals which may be used include platinum, platinum-tungsten, palladium, platinum-iridium, rhodium, tantalum, or alloys or composites of these metals.
[0205] The inventive stents may also be provided with various bio-compatible coatings to enhance various properties of the stent. For example, the inventive stents may be provided with lubricious coatings. The inventive stents may also be provided with drug-containing coatings which release drugs over time. The increased surface area of a stent having bent struts provides for increased drug coatability. The bent struts also provide for point contact with a crimper versus strut/strut contact. Less contact with the crimper results in less disruption of the drug coating.
[0206] The inventive stents may also be provided with a sugar or more generally a carbohydrate and/or a gelatin to maintain the stent on a balloon during delivery of the stent to a desired bodily location. Other suitable compounds for treating the stent include biodegradable polymers and polymers which are dissolvable in bodily fluids. Portions of the interior and/or exterior of the stent may be coated or impregnated with the compound. Mechanical retention devices may also be used to maintain the stent on the balloon during delivery. To that end, the use of other coatings on the inventive stents is also within the scope of the invention.
[0207] The coating may comprise one or more non-genetic therapeutic agents, genetic materials and cells and combinations thereof as well as other polymeric coatings.
[0208] Non-genetic therapeutic agents include anti-thrombogenic agents such as heparin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chIoromethyl ketone); anti-proliferative agents such as enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, and acetylsalicylic acid; anti-inflammatory agents such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, and mesalamine; antineoplastic/antiproliferative/anti-miotic agents such as paclitaxel, 5-fluorouracil, cisplatin, vinblastine, vincristine, epothilones, endostatin, angiostatin and thymidine kinase inhibitors; anesthetic agents such as lidocaine, bupivacaine, and ropivacaine; anti-coagulants such as D-Phe-Pro-Arg chloromethyl keton, an RGD peptide-containing compound, heparin, antithrombin compounds, platelet receptor antagonists, anti-thrombin anticodies, anti-platelet receptor antibodies, aspirin, prostaglandin inhibitors, platelet inhibitors and tick antiplatelet peptides; vascular cell growth promotors such as growth factor inhibitors, growth factor receptor antagonists, transcriptional activators, and translational promotors;
vascular cell growth inhibitors such as growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin; cholesterol-lowering agents;
vasodilating agents; and agents which interfere with endogenous vascoactive mechanisms.
[0209] Genetic materials include anti-sense DNA and RNA, DNA coding for, anti-sense RNA, tRNA or rRNA to replace defective or deficient endogenous molecules, angiogenic factors including growth factors such as acidic and basic fibroblast growth factors, vascular endothelial growth factor, epidermal growth factor, transforming growth factor sand 0, platelet-derived endothelial growth factor, platelet-derived growth factor, tumor necrosis factor a, hepatocyte growth factor and insulin like growth factor, cell cycle inhibitors including CD inhibitors, thymidine kinase ("TK") and other agents useful for interfering with cell proliferation the family of bone morphogenic proteins ("BMP"s"),BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 (Vgr-1), BMP-7 (OP-1), BMP-8, BMP-9, BMP-10, BMP-1 1, BMP-12, BMP-13, BMP-14, BMP-
[001 5] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band. The first pathway is desirably of the same length as the second pathway.
[0016] In one embodiment, each first pathway traverses a total of three peaks and troughs (i.e. two peaks and one trough or one peak and two troughs) and each second pathway traverse a total of five peaks and troughs (i.e. three peaks and two troughs or two peaks and three troughs).
[001 7] In yet another embodiment, the invention is directed to a stent comprising a plurality of circumferential bands where circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands characterized by a first number of alternating first peaks and first troughs and second circumferential bands characterized by a second number of alternating second peaks and second troughs. The second number is different from the first number. The first peaks and troughs are oriented non-parallel to the longitudinal axis of the stent and the second peaks and second troughs are oriented non-parallel to the longitudinal axis of the stent.
Optionally, the first and second circumferential bands each define a pathway around the periphery of the stent and the first and second pathways are the same length.
[0018] Desirably, the peaks and troughs are oriented at an angle of at least degrees with respect to the longitudinal axis of the stent. More desirably, the peaks and troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
[0019] Desirably, the first and second circumferential bands are each characterized by a longitudinal extent with the longitudinal extent of the first circumferential bands exceeding the longitudinal extent of the second circumferential bands.
[0020] Also desirably, first peaks and first troughs which are circumferentially adjacent one another are connected by struts and second peaks and second troughs which are circumferentially adjacent one another are connected by struts. Each of the struts is characterized by a width. The width of the struts of the first bands exceeds the width of the struts of the second bands. Typically, struts which are circumferentially adjacent one another are parallel to one another.
[00211 First and second circumferential bands which are longitudinally adjacent one another may be connected by a single connector or by a plurality of connectors.
The connectors may be of any shape. In one embodiment, straight connectors are used. The connectors may be oriented parallel to the longitudinal axis or, in another embodiment, non-parallel to the longitudinal axis. Connectors with curved portions may also be used.
[0022] The connectors may extend from any region of one band to any region of an adjacent band. In one embodiment, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. In one desirable embodiment, first and second circumferential bands which are longitudinally adjacent one another are connected by a plurality of connectors and the connectors are shorter in length than the longitudinal extent of the second circumferential bands. Circumferentially adjacent connectors may be joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band with the first pathway being of the same length as the second pathway.
[0023] Desirably, the struts in first bands which are longitudinally adjacent one another are non-parallel to one another. More desirably, the struts in first bands which are longitudinally adjacent one another slant in opposing directions relative to the longitudinal axis of the stent.
[0024] In yet another embodiment of the invention, the first circumferential bands are connected to the second circumferential bands via straight connectors which extend between portions of similar curvature on adjacent circumferential bands. Desirably, the connectors extend between peaks of first circumferential bands and peaks of second circumferential bands and between troughs of second circumferential bands and troughs of first circumferential bands.
[0025] Typically, the connectors are shorter in length than the longitudinal extent L, of first circumferential bands.
[0026] In another embodiment, the invention is directed to a stent comprising a sidewall with a plurality of openings therein. Each opening is bounded by at least a first stent member and a second stent member. The first stent member is of a larger width than the second stent member. The first stent member comprises a plurality of bent first struts which extend non-parallel to the longitudinal axis of the stent and the second stent member comprises a plurality of bent second struts which extend non-parallel to the longitudinal axis of the stent. The bent first struts define finger like first projections which are non-parallel to the longitudinal axis of the stent and the bent second struts define finger like second projections which are non-parallel to the longitudinal axis of the stent with the number of second projections exceeding the number of first projections.
[0027] In one embodiment, each opening is defined by first projections which are non-parallel to the second projections.
[0028] In another embodiment, the openings comprise first openings and second openings, with each first opening defined by first projections which are parallel to the second projections. Typically each second opening is defined by first projections which are non-parallel to second projections.
[0029] In another embodiment, the invention is directed to a stent comprising a sidewall, the sidewall having a plurality of openings therein. Each opening is bounded by at least a first stent member and a second stent member. The first stent member is of a larger width than the second stent member. The first stent member comprises a plurality of bent first struts which extend non-parallel to the longitudinal axis of the stent and the second stent member comprises a plurality of bent second struts which extend non-parallel to the longitudinal axis of the stent.
The bent first struts define finger like first projections which are non-parallel to the longitudinal axis of the stent and the bent second struts define finger like second projections which are non-parallel to the longitudinal axis of the stent. The number of first projections exceeds the number of second projections.
[0030] In yet another embodiment, the invention is directed to a stent comprising a plurality of adjacent connected circumferential bands, including first circumferential bands characterized by a first number of alternating first peaks and first troughs joined by bent struts and second circumferential bands characterized by a second number of alternating second peaks and second troughs joined by bent struts where the second number is different from the first number. Each second circumferential band is connected to one adjacent first circumferential band via at least one connector which extends from a peak on the adjacent first circumferential band to a peak on the second circumferential band. Each second circumferential band is also connected to another adjacent first circumferential band via at least one connector which extends from a trough on the another first circumferential band to a trough on the second circumferential band.
[0031] The invention is also directed to a stent comprising a plurality of connected serpentine circumferential bands including a first serpentine circumferential band having a first total circumferential length at a proximal end of the stent, a second serpentine circumferential band having a second total circumferential length at a distal end of the stent and a third serpentine circumferential band having a third total circumferential length between the proximal and distal ends of the stent. The first and second total circumferential lengths differ from one another. Desirably, the first, second and third total circumferential lengths differ from one another. More desirably, the first and second total circumferential lengths are less than the third total circumferential length.
[0032] The invention is also directed to a stent comprising a plurality of connected serpentine circumferential bands. Each serpentine circumferential band comprises a plurality of peaks and troughs. Adjacent peaks and troughs are connected by bent struts. The serpentine circumferential bands include a first serpentine circumferential band having a first total circumferential length at a proximal end of the stent, a second serpentine circumferential band having a second total circumferential length at a distal end of the stent and a third serpentine circumferential band having a third total circumferential length between the proximal and distal ends of the stent. At least one of the first and second total circumferential lengths differs from the third total circumferential length. Desirably, the first, second and third total circumferential lengths differ from one another. More desirably, the first and second total circumferential lengths are less than the third total circumferential length.
[0033] The invention is also directed to a stent comprising a plurality of connected serpentine circumferential bands. Each serpentine circumferential band comprises a plurality of peaks and troughs with adjacent peaks and troughs connected by bent struts. Adjacent serpentine circumferential bands are connected one to the other in one or more regions of overlap where a peak in one serpentine band overlaps with a trough in an adjacent serpentine circumferential band.
The one or more regions of overlap extend in a longitudinal direction.
[0034] The invention is also directed to a stent comprising a plurality of connected serpentine circumferential bands. Each serpentine circumferential band comprises a plurality of peaks and troughs. Adjacent peaks and troughs are connected by nested bent struts. Serpentine circumferential bands which are adjacent one another are connected via a plurality of connections. The stent includes two serpentine circumferential bands which are connected via a first number of connections and two serpentine circumferential bands which are connected via a second number of connections, the second number different from the first number.
[0035] The invention is also directed to a stent comprising a plurality of adjacent serpentine circumferential bands containing alternating troughs and peaks.
Adjacent serpentine circumferential bands have a plurality of cells therebetween. At least two adjacent serpentine circumferential bands have a plurality of first cells therebetween and a plurality of second cells therebetween. The second cells are larger than the first cells.
[0036] The invention is also directed to a stent comprising a plurality of serpentine circumferential bands including a first serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by bent struts and a second serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by relatively straight struts. The first and second serpentine circumferential bands are connected to one another.
[0037] Without being bound by theory, bent struts have been found to provide more wall coverage than straight struts. Furthermore, using bent struts typically requires more material, i.e. metal, and thus provides improved radiopacity as well.
[0038] Additional details and/or embodiments of the invention are discussed below.
Brief Description of Drawings [0039] Fig. 1 a is a flat layout view of an inventive stent.
[0040] Fig. 1 b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 1 a.
[0041] Fig. 2a is a flat layout view of an embodiment of the inventive stent of the present invention which is similar to that shown in Fig. 1 a.
[0042] Fig. 2b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 2a.
[0043] Fig. 3a shows an alternative embodiment of the inventive stent of the present invention.
[0044] Fig. 3b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 3a.
[0045] Fig. 4a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0046] Fig. 4b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 4a.
[0047] Fig. 5a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0048] Fig. 5b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 5a.
[0049] Fig. 6a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0050] Fig. 6b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 6a.
[0051] Fig. 7a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0052] Fig. 7b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 7a.
[0053] Fig. 8a is a flat layout view of an embodiment of the inventive stent of the present invention.
[0054] Fig. 8b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 8a.
[0055] Fig. 9a is a flat layout view of an inventive stent of the present invention.
[0056] Fig. 9b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 9a.
[0057] Fig. 10a is a flat layout view of an inventive stent of the present invention.
[0058] Fig. 10b shows an enlarged view of region A of the stent shown in flat layout view in Fig. 10a.
[0059] Fig. 11 shows a flat layout view of an alternative embodiment of the inventive stent of the present invention.
[0060] Figs. 12-19 show flat layout views of other embodiments of the inventive stents of the present invention, the stents having large and small amplitude circumferential bands. Figs. 1 2a-1 9a show enlarged views of selected regions of the stents of Figs. 12-19.
[0061] Figs. 20-25 show flat layout views of other embodiments of the inventive stents of the present invention, the stents having circumferential bands of the same amplitude. Figs. 20a-25a show enlarged views of selected regions of the stents of Figs. 20-25.
[0062] Figs. 26-45 show flat layout views of other embodiments of the inventive stents of the present invention, the stents having overlapping circumferential bands.
Figs. 26a-45a show enlarged views of selected regions of the stents of Figs.
26-45.
[0063] Fig. 46 shows other connectors which may be used in the inventive stents.
Detailed Description [0064] While this invention may be embodied in many different forms, there are described in detail herein specific embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
[0065] For the purposes of this disclosure, like reference numerals in the figures shall refer to like features unless otherwise indicated.
[0066] Also for the purposes of this disclosure, the term 'bent strut' does not implicate a method of manufacture and is intended to include struts which have curves, struts which are angled, and struts which are curvilinear, regardless of how the struts or the stent as a whole are manufactured. Bent struts as referred to herein typically have two segments joined by a bent portion.
[0067] Finally, for the purposes of this disclosure, the expression 'total circumferential length' refers to the length of a circumferential band as the band is traversed about the circumference of the stent.
[0068] In one embodiment, the invention is directed to a stent such as that shown by way of example at 100 in Fig. 1 a comprising a plurality of circumferential bands. Circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 104 characterized by a first number of alternating first peaks 106 and first troughs 108 joined by bent struts 1 1 0 and second circumferential bands 1 12 characterized by a second number of alternating second peaks 114 and second troughs 1 16 joined by bent struts, 118. Typically, as shown in Fig. 1 a, the second number of second peaks and troughs is different from the first number of first peaks and troughs and desirably exceeds the first number.
[0069] The first and second circumferential bands each define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of different lengths. Desirably, the first and second pathways are the same length.
[0070] Also desirably, the first and second peaks and first and second troughs are oriented at an angle between 0 and 70 with respect to the longitudinal axis of the stent, more desirably they are oriented at an angle of at least 10 degrees with respect to the longitudinal axis of the stent, and most desirably, the first and second peaks and first and second troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
[00711 Typically, as shown in Fig. 1 b, the first and second circumferential bands may be characterized by longitudinal extents L, and L2. The longitudinal extent of each first circumferential band L, desirably exceeds the longitudinal extent L2 of the individual second circumferential bands.
[0072] Each of the bent struts may be characterized by a width. Optionally, the width of the bent struts of the first bands W, exceeds the width of the bent struts of the second bands W2-[0073] Desirably, as shown in Fig. 1 a, bent struts which are circumferentially adjacent one another are parallel to one another. More desirably, as shown in Fig.
1 a, bent struts in longitudinally adjacent first and second circumferential bands are non-parallel to one another.
[0074] In one embodiment of the invention, as shown in Fig. 1 a, first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 120 and desirably, by a plurality of connectors.
Typically, the connectors will be straight and non-parallel to the longitudinal axis 101 of the stent. In other embodiments of the invention, other types of connectors may be used for example connectors with one or more curves and/or connectors of different lengths. Desirably, as shown in Fig. 1 a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. Also desirably, as shown in Fig. I a, the connectors are shorter in length than the longitudinal extent L2 of the second circumferential bands.
[0075] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0076] In the embodiment of Fig. 1 a, each first pathway traverses a total of three peaks and troughs (i.e. two peaks and one trough or one peak and two troughs) and each second pathway traverse a total of five peaks and troughs (i.e. three peaks and two troughs or two peaks and three troughs).
[0077] In other words, between circumferentially adjacent connectors which connect first and second circumferential bands together, in the first band, there are a total of three peaks and troughs between the connectors, and in the second circumferential band there are a total of five peaks and troughs between connectors.
[0078] Without being bound by theory, the alternating orientation of adjacent first and second circumferential bands is believed to prevent significant rotation and build-up of torque and the accompanying degradation of stent performance.
[0079] In another embodiment, the invention is directed to a stent such as that shown by way of example at 100 in Fig. 2a comprising a plurality of circumferential bands substantially similar to those shown in Fig. 1 a. As in the embodiment shown in Fig. 1 a, the first and second circumferential bands each define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of different lengths. Desirably, the first and second pathways are the same length.
[0080] Also as in the embodiment shown in Fig. 1 a, the first circumferential bands 104 are characterized by a first number of alternating first peaks 106 and first troughs 108 joined by bent struts 1 1 0 and second circumferential bands 1 12 characterized by a second number of alternating second peaks 1 14 and second troughs 1 16 joined by bent struts, 118. Typically, as shown in Fig. 1 a, the second number of second peaks and troughs is different from the first number of first peaks and troughs and desirably exceeds the first number.
[0081] In the embodiment shown in Fig. 2a, however, in contrast to that shown in Fig. 1 a, the connectors do not extend between the nearest neighboring peaks and troughs, but rather every first peak of every first circumferential band 104 is connected to every third trough of a second adjacent circumferential band.
[0082] As in Fig. 1 b, the first and second circumferential bands may be characterized by longitudinal extents L, and L2 as shown in Fig. 2b. The longitudinal extent of each first circumferential band L, desirably exceeds the longitudinal extent L2 of the individual second circumferential bands.
[0083] Again as in Fig. 1 a, the first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 120 and desirably, by a plurality of connectors. Desirably, as shown in Fig. 2a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands as in Fig. 1 a. However, in the embodiment shown in Fig.
2a, the connectors are significantly longer in length than the longitudinal extent L2 of the second circumferential bands.
[0084] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0085] In the embodiment shown in Fig. 2a, each first pathway traverses a total of four peaks and troughs (i.e. two peaks and two troughs) and each second pathway traverse a total of six peaks and troughs (i.e. three peaks and three troughs).
[0086] In another embodiment, the invention is directed to a stent such as that shown by way of example at 300 in Fig. 3a comprising a plurality of circumferential bands. This embodiment is also similar to the embodiments shown in Fig. 1 a and 2a. Circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 304 characterized by a first number of alternating first peaks 306 and first troughs 308 joined by bent struts 310 and second circumferential bands 312 characterized by a second number of alternating second peaks 314 and second troughs 316 joined by bent struts. The number of second peaks and troughs is different from the number of first peaks and troughs and desirably exceeds the first number.
[0087] The first and second circumferential bands each define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of different lengths but are desirably the same length.
[0088] As shown in Fig. 3b, the first and second troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis 301 of the stent.
More desirably, the first and second peaks and first and second troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent. In the particular embodiment shown in Fig. 3b, the first and second peaks and first and second troughs, are actually oriented at an angle of about 40 degrees with respect to the longitudinal axis of the stent.
[0089] Typically, as shown in Fig. 3b, the first and second circumferential bands may be characterized by longitudinal lengths L, and Lz which may be of the same length, or of a different length. Desirably, L, exceeds the longitudinal extent L2 of the individual second circumferential bands.
[0090] Each of the bent struts may be characterized by a width. Optionally, the width of the bent struts of the first bands W, exceeds the width of the bent struts of the second bands W2.
[00911 The first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 320 and preferably by a plurality of connectors. In this particular embodiment, the connectors are straight, and are non-parallel to the longitudinal axis 301 of the stent 300. Also in the embodiment shown in Fig. 3a, the connectors are significantly shorter than the longitudinal extent of the circumferential bands L2. Other connectors may be optionally used, however including connectors having more curves or being of a different length.
[0092] In this embodiment, the connectors extend between peaks of circumferential bands to troughs of adjacent circumferential bands. In this particular embodiment, the connectors are shorter in length than the extent L2 of the second circumferential bands.
[0093] This may be optionally described in terms of first and second pathways.
Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0094] In the embodiment shown in Fig. 3a, the first pathway traverses a total of four peaks and troughs (two peaks and two troughs) and the second pathway traverses a total of six peaks and troughs (three peaks and three troughs).
[0095] Fig. 4a illustrates an embodiment similar to those shown in Figs. 1 a-3a as described above.
[0096] Again, there are first and second circumferential bands which define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of different lengths but are desirably the same length.
[0097] The first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 420 and preferably by a plurality of connectors. In this particular embodiment, the connectors are straight, and are non-parallel to the longitudinal axis 401 of the stent 400. Other connectors may be optionally used, however including connectors having more curves or being of a different length.
[0098] In this embodiment, the connectors extend between peaks of circumferential bands to troughs of adjacent circumferential bands. In this particular embodiment, the connectors are shorter in length than the extent L2 of the second circumferential bands.
[0099] This may be optionally described in terms of first and second pathways.
Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0100] Again, as in the embodiment shown in Fig. 3a, the embodiment shown in Fig. 4a includes a first pathway which traverses a total of four peaks and troughs (two peaks and two troughs) and the second pathway traverses a total of six peaks and troughs (three peaks and three troughs).
[0101 ] The connectors in the embodiment shown in Fig. 4a are at a different angle relative to the longitudinal axis 401 of stent 400 than those shown in Fig. 3a, the angle being smaller relative to the longitudinal axis in the embodiment shown in Fig. 4a.
[0102] An alternative embodiment of the inventive stent of the present invention is shown generally at 500 in Fig. 5a and again includes a plurality of circumferential bands. Circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 504 characterized by a first number of alternating first peaks 506 and first troughs 508 joined by bent struts 510 and second circumferential bands 512 characterized by a second number of alternating second peaks 514 and second troughs 516 joined by bent struts 518. In this particular embodiment, the number of second peaks and troughs is the same as the number of first peaks and troughs.
[0103] The first and second circumferential bands each define a pathway around the periphery of the stent. The first and second pathways may be of the same length or of a different length. In the embodiment shown in Fig. 5a, the first and second pathways are of the same length.
[0104] The first and second peaks and first and second troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis 501 of the stent 500, and desirably are oriented at an angle of at least 15 degrees with respect to the longitudinal axis 501.
[0105] In this particular embodiment, as shown in Fig. 5b, the longitudinal extent L, of the first circumferential band is substantially equal in length to the longitudinal extent L2 of the second circumferential band.
[0106] Also in the embodiment shown in Fig. 5b, the width of each of the bent struts of the first bands W, is equal to the width of the bent struts of the second bands W2. Optionally, the widths may be different. For example, the width of the first bands W, may exceed the width of the second bands W2.
[0107] In the embodiment shown in Fig. 5a, first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 520 and desirably, by a plurality of connectors. Typically, in this embodiment, the connectors will be curved as opposed to the straight connectors as shown in some of the other embodiments. In this embodiment, the connectors extend from the troughs of circumferential bands to troughs of adjacent circumferential bands. The connectors are shown longer in length than the longitudinal extents L, and L2 of the circumferential bands.
[0108] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway. Each first pathway traverses a total of six peaks and troughs (three peaks and three troughs) and each second pathway traverses a total of six peaks and troughs (three peaks and three troughs).
[0109] In yet another alternative embodiment of the inventive stent of the present invention shown generally at 600 in Fig. 6a, the stent includes a plurality of circumferential bands wherein circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 604 characterized by a first number of alternating first peaks 606 and first troughs 608 and second circumferential bands 612 characterized by a second number of alternating second peaks 614 and second troughs 616. The second number is different from the first number. The first peaks and troughs are oriented non-parallel to the longitudinal axis 601 of the stent 600 and the second peaks and second troughs are oriented non-parallel to the longitudinal axis 601 of the stent. Desirably, the peaks and troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis of the stent. More desirably, the peaks and troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
[01101 The first and second circumferential bands each define a pathway around the periphery of the stent and the first and second pathways are the same length.
[01111 The stent is further characterized by bent struts which exhibit a configuration similar to finger-like projections. Each of the bent struts may be characterized by a width. Optionally, the width of the bent struts of the first bands W, exceeds the width of the bent struts of the second bands W2-[Oil 2] Desirably, as shown in Fig. 6a, bent struts which are circumferentially adjacent one another are parallel to one another. Bent struts in longitudinally adjacent first and second circumferential bands may or may not be parallel to one another, however.
[0113] In the embodiment shown in Fig. 6a, first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 620 and desirably, by a plurality of connectors. Typically, the connectors will be substantially straight and non-parallel to the longitudinal axis 601 of the stent. In other embodiments of the invention, other types of connectors may be used for example connectors with one or more curves and/or connectors of different lengths. Desirably, as shown in Fig. 6a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. Also desirably, as shown in Fig. 6a, the connectors are similar in length to the longitudinal extent L2 of the second circumferential bands.
[Oil 4] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[Oil 5] In the embodiment of Fig. 6a, each first pathway traverses a total of four peaks and troughs (i.e. two peaks and two troughs) and each second pathway traverse a total of six peaks and troughs (i.e. three peaks and three troughs).
[01 16] Yet another alternative embodiment of the inventive stent of the present invention is shown generally at 700 in Fig. 7a, the stent includes a plurality of circumferential bands wherein circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 704 characterized by a first number of alternating first peaks 706 and first troughs 708 and second circumferential bands 712 characterized by a second number of alternating second peaks 714 and second troughs 716. The second number is different from the first number. The first peaks and troughs are oriented non-parallel to the longitudinal axis 701 of the stent 700 and the second peaks and second troughs are oriented non-parallel to the longitudinal axis 701 of the stent. Desirably, the peaks and troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis of the stent. More desirably, the peaks and troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
[0117] The first and second circumferential bands each define a pathway around the periphery of the stent and the first and second pathways are the same length.
[0118] The stent is further characterized as having bent struts exhibiting finger-like projections which are similar to those in the embodiment shown in Fig.
6a. Each of the bent struts may be characterized by a width. Optionally, the width of the bent struts of the first bands W, exceeds the width of the bent struts of the second bands [Oil 91 Desirably, as shown in Fig. 7a, bent struts which are circumferentially adjacent one another are parallel to one another. Bent struts in longitudinally adjacent first and second circumferential bands may or may not be parallel to one another, however.
[0120] In the embodiment shown in Fig. 7a, first and second circumferential bands which are longitudinally adjacent one another are connected by at least one connector 720 and desirably, by a plurality of connectors. Typically, the connectors are slightly curvilinear and are non-parallel to the longitudinal axis 701 of the stent.
In other embodiments of the invention, other types of connectors may be used for example connectors with one or more curves and/or connectors of different lengths.
Desirably, as shown in Fig. 7a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. Also desirably, as shown in Fig.
7a, the connectors are shorter in length than the longitudinal extent Li of the second circumferential bands.
[0121] Where a plurality of connectors are present between adjacent first and second circumferential bands, circumferentially adjacent connectors are joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway.
[0122] In the embodiment of Fig. 7a, each first pathway traverses a total of four peaks and troughs (i.e. two peaks and two troughs) and each second pathway traverse a total of six peaks and troughs (i.e. three peaks and three troughs).
[0123] An alternative embodiment of the inventive stent of the present invention is shown in Fig. 8a. In this embodiment, the stent is substantially similar to that shown in Fig. 7a. The connectors 820 shown in the embodiment in Fig. 8a are straight while those shown in Fig. 7a are slightly curvilinear. The connectors 820 are again shorter in shorter in length than the longitudinal extent L2 of the second circumferential bands.
[0124] Again, a plurality of connectors are shown present and between adjacent first and second circumferential bands. The circumferentially adjacent connectors are again joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band, the first pathway desirably being of the same length as the second pathway. Again in the embodiment of Fig. 8a, each first pathway traverses a total of four peaks and troughs (i.e. two peaks and two troughs) and each second pathway traverse a total of six peaks and troughs (i.e.
three peaks and three troughs).
[0125] Desirably, as shown in Fig. 9b, the first and second circumferential bands 204 and 212 are each characterized by a longitudinal extent with the longitudinal extent L, of each the first circumferential bands exceeding the longitudinal extent L2 of the second circumferential bands.
[0126] In yet another embodiment, as shown generally at 200 in Fig. 9a, the invention is directed to a stent including a plurality of circumferential bands where circumferential bands which are adjacent one another are connected one to the other. The circumferential bands include first circumferential bands 204 characterized by a first number of alternating first peaks 206 and first troughs 208 and second circumferential bands 212 characterized by a second number of alternating second peaks 214 and second troughs 216. The second number is different from the first number. The first peaks and troughs are oriented non-parallel to the longitudinal axis 201 of the stent and the second peaks and second troughs are oriented non-parallel to the longitudinal axis of the stent.
Desirably, the peaks and troughs are oriented at an angle of at least 10 degrees with respect to the longitudinal axis of the stent. More desirably, the peaks and troughs are oriented at an angle of at least 15 degrees with respect to the longitudinal axis of the stent.
Optionally, the first and second circumferential bands each define a pathway around the periphery of the stent and the first and second pathways are the same length.
[0127] Desirably, as shown in Fig. 9b, the first and second circumferential bands 204 and 212 are each characterized by a longitudinal extent with the longitudinal extent L, of each the first circumferential bands exceeding the longitudinal extent L2 of the second circumferential bands.
[0128] Also desirably, first peaks and first troughs which are circumferentially adjacent one another are connected by struts 21 8a and second peaks and second troughs which are circumferentially adjacent one another are connected by struts 21 8b. Each of the struts is characterized by a width with the width W, of the struts of the first circumferential bands exceeding the width W2 of the struts of the second circumferential bands.
[0129] Typically, as shown in Fig. 9a, struts which are circumferentially adjacent one another are parallel to one another.
[0130] First and second circumferential bands which are longitudinally adjacent one another may be connected by a single connector or by a plurality of connectors.
The connectors may be of any shape. In one embodiment, as shown in Fig. 9a, straight connectors 220 may be used. The connectors may be oriented non-parallel to the longitudinal axis, as shown in Fig. 9b or, in another embodiment, oriented parallel to the longitudinal axis.
[0131] The connectors may extend from any region of one circumferential band to any region of an adjacent circumferential band. In the embodiment of Fig.
9a, the connectors extend from peaks of circumferential bands to troughs of adjacent circumferential bands. In the embodiment of Fig. 9a, first and second circumferential bands 204 and 212 which are longitudinally adjacent one another are connected by a plurality of connectors 220 and the connectors are shorter in length than the longitudinal extent L2 of the second circumferential bands.
Circumferentially adjacent connectors may be joined via a first pathway along a first circumferential band and a second pathway along a second circumferential band with the first pathway desirably being of the same length as the second pathway.
[0132] Desirably, as shown in Fig. 9a, the struts 21 8a in first circumferential bands which are longitudinally adjacent one, for example first circumferential bands 204a and 204b, are non-parallel to one another. More desirably, as shown in Fig 9a, the struts in first circumferential bands which are longitudinally adjacent one another slant in opposing directions relative to the longitudinal axis of the stent.
Without being bound by theory, the alternating orientation of adjacent first circumferential bands is believed to prevent significant rotation and build-up of torque and the accompanying degradation of stent performance.
[0133] In another embodiment of the invention, the first circumferential bands are connected to the second circumferential bands via straight connectors which extend between portions of similar curvature on adjacent circumferential bands. As shown by way of example in Fig. I Oa, connectors 220a extend between peaks 206 of first circumferential band 204a and peaks 214 of second circumferential band 212.
Connectors 220b extend between troughs 216 of second circumferential band 212 and troughs 208 of first circumferential bands 204b.
[0134] In the embodiment of Fig. 10a, connectors 220a and 220b are shorter in length than the longitudinal extent Li of first circumferential bands 204 but longer than the connectors of the embodiment of Fig. 1 Oa. In other embodiments of the invention, longer connectors may be used. Any of the other connectors disclosed herein may also be used to achieve different properties.
[0135] The invention is also directed to other embodiments in which the orientation of the struts in the first circumferential bands alternates between consecutive first circumferential bands relative to the longitudinal axis. In the embodiment of Fig. 11, the orientation of the struts in adjacent first circumferential bands 304a,b relative to the longitudinal axis alternates. Moreover, each second circumferential band 31 2a,b may comprise a plurality of consecutive struts 307' oriented in a first direction relative to the longitudinal axis of the stent and a plurality of consecutive struts 307" oriented in a second direction opposite the first direction and relative to the longitudinal axis of the stent. Adjacent circumferential bands are connected via connectors 329. Desirably, in the embodiment of Fig.
11, the connectors are oriented longitudinally. Any of the other connectors disclosed herein may be used to achieve stents with other characteristics.
[0136] First circumferential bands 304a,b may be longer or the same length about the periphery of the stent as second circumferential bands 31 2a,b.
First circumferential bands 304a,b are desirably wider than second circumferential bands 31 2a,b. Also desirably, the first circumferential bands have fewer peaks and troughs than the second circumferential bands.
[0137] It is further within the scope of the invention to vary the number of connectors extending between adjacent circumferential bands in any of the embodiments disclosed herein. For example, adjacent circumferential bands in the middle of the stent may be joined by more connectors than adjacent circumferential bands at the proximal and/or distal ends of the stent so that the proximal and/or distal ends of the stent are more flexible. The middle portion of the stent may have fewer connectors than the proximal and/or distal ends of the stent to achieve greater flexibility in the middle of the stent than in the proximal and/or distal ends of the stent. The number of connectors may increase over the length of the stent to provide a stent with increasing rigidity over its length.
[0138] The invention is also directed to a stent such as that shown by way of example in Fig. 1 a, comprising a sidewall with a plurality of openings 122 therein.
Each opening is bounded by at least a first stent member and a second stent member. The first stent member 134 (shown shaded) is of a larger width than the second stent member 142 (shown shaded). The first stent member 134 comprises a plurality of bent first struts 110 which extend non-parallel to the longitudinal axis 101 of the stent and the second stent member 142 comprises a plurality of bent second struts 1 18 which extend non-parallel to the longitudinal axis of the stent.
The bent first struts define finger like first projections 124 (shown shaded) which are non-parallel to the longitudinal axis of the stent and the bent second struts define finger like second projections 126 which are non-parallel to the longitudinal axis of the stent with the number of first projections exceeding the number of second projections.
[0139] Desirably, as shown in the embodiment of Fig. 1 a, each opening is defined by first projections which are non-parallel to second projections.
[0140] In another embodiment, as shown by way of example in Fig. 9a, the stent comprises a plurality of openings including first openings 222a and second openings 222b. Each first opening 222a includes first projections 224a which are parallel to second projections 226a. Each second opening 222b includes first projections 224b which are non-parallel to second projections 226b.
[01411 The stent of Fig. 9a also has first openings and second openings where each first opening includes first projections which are parallel to second projections.
Each second opening includes first projections which are non-parallel to second projections.
[0142] In another embodiment, the invention is directed to a stent such as that shown at 100 in Fig. 12 comprising a plurality of circumferential bands.
Circumferential bands which are adjacent one another are connected one to the other. At least a portion of the stent, and, desirably, as shown in Fig. 12, the entirety of the stent consists of first circumferential bands 104 characterized by a first number of alternating first peaks 106 and first troughs 108 joined by bent struts 1 1 0 and second circumferential bands 1 12 characterized by a second number of alternating second peaks 114 and second troughs 1 16 joined by bent struts 118.
Typically, as shown in Fig. 12, the second number of second peaks and troughs is different from the first number of first peaks and troughs and desirably exceeds the first number. First circumferential bands which are adjacent to second circumferential bands are connected thereto by at least one, and desirably, as shown in Fig. 12, a plurality of connectors 120. Connectors 120 extend from troughs of first circumferential bands to troughs of second circumferential bands and from peaks of second circumferential bands to peaks of first circumferential bands.
Connectors 120 are bent and are generally parallel to the struts of the first circumferential bands.
[0143] In the embodiment of Fig. 12, with the exception of the connectors of the end bands, each connector which extends in distal direction is separated by one struts 11 Ofrom a connector extending in a distal direction.
[0144] In the embodiment of Fig. 13, adjacent first circumferential bands 104 and second circumferential bands 1 12 are connected to one another via one and desirably a plurality of connectors 120 which extend from peaks 106 of first circumferential bands to troughs 116 of second circumferential bands 112 and from peaks 1 1 4 of second circumferential bands 1 12 to troughs 108 of first circumferential bands 104. Connectors 120 are desirably significantly shorter than the struts of the second circumferential band 112. More desirably, the length of connectors 120 is on the order of magnitude of the width of the struts 110 of first circumferential band 104. As shown in Fig. 13, each connector which extends in a distal direction is separated from a connector extending in a proximal direction by three struts. Connectors 120 are straight and oriented parallel to the longitudinal axis.
[0145] In the embodiment of Fig. 13, as well as in many of the other embodiments of the invention, connectors 120 do not extend from the center of the peaks and troughs but rather extend from corners of the peaks and troughs. In the embodiment of Fig. 12, connectors extend from the center of the peaks and troughs.
[0146] The individual sections 1 10a and 1 10b of bent struts 1 10 of the inventive stent of Fig. 13 extend at a more gradual angle relative to the longitudinal axis of the stent than the individual sections of the bent struts of the stent of Fig.
12.
Specifically, the sections of the bent struts of the stent of Fig. 12 extend at a 40 degree angle relative to the longitudinal axis and the sections of the bent struts of the stent of Fig. 13 extend at a 30 degree angle relative to the longitudinal axis.
[0147] Depending on the alignment of adjacent circumferential bands, the connectors may also be at an angle relative to the longitudinal axis as shown in Fig.
14. Connectors 120 are non-parallel to the longitudinal axis, extending at an oblique angle relative to the longitudinal axis. In the stent of Fig. 14, the orientation of connectors relative to the longitudinal axis reverses along the length of the stent with connectors 1 20a extending in a first direction and connectors 120b extending in a second opposite direction relative to the longitudinal axis of the stent.
[0148] In the embodiment of Fig. 1 5, the sections 1 10a and 1 10b of the bent struts 1 10 extend at a 40 degree angle relative to the longitudinal axis of the stent.
Straight connectors 120 are provided between adjacent circumferential bands and 112.
[0149] In the embodiment of Fig. 16, adjacent first and second circumferential bands 104 and 1 12 are spaced further apart from one another than in some of the previous embodiments. As a result, connectors 120 are longer than in other embodiment where the connectors extend between peaks and troughs. Also, the bent struts 1 10 of the first circumferential bands 104 are much closer in width to the bent struts 1 10 of the second circumferential bands 112.
[01 50] Fig. 17 is an embodiment with narrower bent struts in the first circumferential bands and with connectors 120 which are parallel to the longitudinal axis of the stent.
[01511 The embodiment of Fig. 18 is similar to that of Fig. 17, differing in part in that the sections of the bent struts extend at a 40 degree angle relative to the longitudinal axis rather than the 30 degree angle of the struts of Fig. 17.
[0152] The stent of Fig. 19 comprises first circumferential bands 104 which have bent struts 1 1 0 and second circumferential bands 1 12 which have relatively straight struts which are not parallel to the longitudinal axis of the stent. The orientation of the struts of the second circumferential bands reverses along the length of the stent.
Connectors 120 extend from peaks 106 of first circumferential bands 104 to peaks 114 of second circumferential bands 1 12 and from troughs 116 of second circumferential bands 1 12 to troughs 108 of first circumferential bands 104.
[01 53] In the embodiment of Fig. 20, adjacent circumferential bands 104 are of the same longitudinal extent and have an identical number of peaks 106 and an identical number of troughs 108. Connectors 120 extend from peaks 106 of circumferential bands 104 to troughs 108 of adjacent circumferential bands 104 and from troughs 106 of circumferential bands 104 to peaks 106 of adjacent circumferential bands 104. The connectors 120 are parallel to the longitudinal axis of the stent.
[01 54] In the embodiment of Fig. 26, adjacent circumferential bands 104 share one or more members 130 in common. One or more peaks 106a of one circumferential band 104 are longer than the remaining peaks 1 06b and one or more troughs 1 08a of the adjacent circumferential band 104 are longer than the remaining troughs 1 08b. The longer peaks 1 06a intersect with the longer troughs 1 08a and share a member 130 in common forming an H-shaped structure 132. The resulting H-shaped structure in the embodiment of Fig. 26 is oriented at an oblique angle relative to the longitudinal axis of the stent with the cross-bar portion 130 of the 'H' shaped structure extending in a circumferential direction. In other embodiments of the invention, cross-bar portion 130 of the H-shaped member is oriented in a longitudinal direction, as shown for example in Fig. 30, or in a circumferential direction, as shown for example, in Fig. 31.
[01 55] In the embodiment of Fig. 26, there are three overlapping regions 130 between adjacent circumferential bands 104. The distal end of each cell 136 is defined by two full peaks 106 and two full troughs 108 and the proximal end of each cell 136 is defined by two full peaks 106 and two full cells 136. It is also within the scope of the invention for there to be fewer overlapping regions 130 between adjacent circumferential bands 104 or more overlapping regions 130 between adjacent circumferential bands 104. In the embodiment of Fig. 27, there are four overlapping regions 130 between adjacent circumferential bands 104. The distal end of each cell 136 is defined by three full peaks 106 and three full troughs and the proximal end of each cell 136 is defined by three full peaks 106 and three full troughs 136. The 'H' shaped structures 132 extend in an oblique direction relative to the longitudinal axis of the stent.
[0156] In the stents of Figs. 26-37 it is also noted that the total circumferential length of the proximal and distal most circumferential bands 1 04a is less than the total circumferential length of the other circumferential bands 1 04b.
Desirably, the difference in total circumferential length is on the order of 5%. In another embodiment of the invention, the proximal and distal most circumferential bands are of the same total circumferential length as the other circumferential bands.
In another embodiment of the invention, the proximal and distal most circumferential bands are of greater total circumferential length than the other circumferential bands. In yet another embodiment of the invention only of the proximal and distal most circumferential bands are of greater total circumferential length than the other circumferential bands. In yet another embodiment of the invention only of the proximal and distal most circumferential bands are of lesser total circumferential length than the other circumferential bands. Finally, in yet another embodiment of the invention one of the proximal and distal most circumferential bands is of greater total circumferential length than the other circumferential bands and the other of the proximal and distal most circumferential bands is of lesser total circumferential length than the other circumferential bands.
[015 71 In the stents of Figs. 43-45, the proximal-most and distal-most circumferential bands 1 04a,c are of different total circumferential lengths than the remainder of the circumferential bands 1 04b. In this case, they are shorter than the other circumferential bands 104b. Moreover, the proximal-most bands 1 04a are of shorter total length than the distal-most circumferential band 1 04c. In the stents of Figs. 43-45, adjacent circumferential bands 104 have regions 130 of overlap.
More generally, the invention is directed to stents comprising circumferential bands wherein the proximal-most and distal-most circumferential bands are of less total circumferential length than the remainder of the circumferential bands and one of the proximal-most and distal-most circumferential bands is shorter than the other.
The circumferential bands may overlap one another or may be connected by connecting which extend through gaps separating adjacent circumferential bands.
[0158] The stents of Figs. 43-45 is also notable in that the number of overlapping regions 130 alternates between 2 and 3 along the length of the stent.
This results in alternating regions having three cells 136 extending about the circumference of the stent and regions having two cells 136 extending about the circumference of the stent. More generally, the invention is directed to stents having alternating numbers of overlapping regions or connections between adjacent bands along the length of the stent. Thus, the number of overlapping regions or connections between adjacent bands will alternate between N and M where N and M
are different integers greater than or equal to 1. The invention is also directed to stents having alternating numbers of cells in circumferential bands along the length of the stent. Thus, the number of cells arranged about the circumference of the stent will alternate between N and M along the length of the stent where N and M are different integers greater than or equal to 1.
[0159] The stents of Figs. 43-45 also have more cells disposed about the circumference at one end than at the other end.
[0160] The invention is also direct to a stent such as that shown by way of example in Fig. 12, comprising a plurality of circumferential bands, with adjacent circumferential bands connected one to the other via a plurality of connectors. The circumferential bands include first circumferential bands 104 characterized by a first number of alternating first peaks 106 and first troughs 108 joined by bent struts 110 and second circumferential bands 112 characterized by a second number of alternating second peaks 114 and second troughs 1 16 joined by bent struts 118.
The second number is different from the first number. Each second circumferential band 1 12 is connected to one adjacent first circumferential band 104 via at least one connector 120 and desirably a plurality of connectors 120. The one or more connectors 120 extend from peaks 106 on the adjacent first circumferential band 104 to peaks 1 14 on the second circumferential band 112. Each second circumferential band 1 12 is also connected to another adjacent first circumferential band 104 via one or more connectors 120 extending from troughs 108 on the another first circumferential band 104 to troughs 1 16 on the second circumferential band 112.
[01611 Desirably, the connectors 120 are not straight. More desirably, as shown in Fig. 12, the connectors 120 are substantially parallel to the bent struts 110 of the first circumferential bands 104.
[0162] In the embodiment of Fig. 12, the first and second circumferential bands are each characterized by a longitudinal extent and the longitudinal extent of each first circumferential band 104 exceeds the longitudinal extent of each second circumferential band 112. It is also within the scope of the invention for the first and second circumferential bands to be of the same longitudinal extent.
[0163] Also, in the embodiment of Fig. 12, the first circumferential bands 104 are each characterized by a first total circumferential length and the second circumferential bands 1 12 are each characterized by a second total circumferential length and the first total circumferential length is equal to the second total circumferential length. In other embodiments of the invention, the first and second circumferential bands may be of different total circumferential lengths.
[0164] The invention is also directed to a stent, such as that shown by way of example in Fig. 43, comprising a plurality of serpentine circumferential bands 104.
Adjacent serpentine circumferential bands 104 are connected one to the other.
The serpentine circumferential bands 104 include a first serpentine circumferential band 1 04a having a first total circumferential length at a proximal end of the stent, a second serpentine circumferential band 1 04b having a second total circumferential length at a distal end of the stent and a third serpentine circumferential band 1 04c having a third total circumferential length between the proximal and distal ends of the stent. The first and second total circumferential lengths differ from one another.
Desirably, the first, second and third total circumferential lengths differ from one another. More desirably, the first and second total circumferential lengths are less than the third total circumferential length.
[0165] As shown in Fig. 43, the serpentine circumferential bands include a band 1 04a of a first longitudinal extent and a band 104b of a second longitudinal extent different from, and desirably, less than the first longitudinal extent. The first longitudinal extent is greater than the second longitudinal extent.
[0166] The stent may optionally have serpentine circumferential bands having a first number of peaks and troughs and serpentine circumferential bands having a second number of peaks and troughs, the second number less than the first number, as shown for example in Fig. 12.
[0167] Desirably, as shown in Fig. 43, each serpentine circumferential band 104a-c comprises a plurality of peaks 106 and troughs 108 with bent struts 1 extending between adjacent peaks 106 and troughs 108. Circumferentially adjacent bent struts 1 10 are nested as they are in many other embodiments disclosed herein.
[0168] The invention is also directed to a stent such as that shown by way of example in Fig. 43, comprising a plurality of interconnected serpentine circumferential bands 1 04a-c, each comprising a plurality of peaks 106 and troughs 108. Adjacent peaks 106 and troughs 108 are connected by bent struts 110. The bent struts 110 are arranged in a nested relationship. The serpentine circumferential bands 104 include a first serpentine circumferential band 1 04a having a first total circumferential length at a proximal end of the stent, a second serpentine circumferential band 104b having a second total circumferential length at a distal end of the stent and a third serpentine circumferential band 1 04c having a third total circumferential length between the proximal and distal ends of the stent.
At least one of the first and second total circumferential lengths differs from the third total circumferential length.
[0169] Desirably, as shown in Fig. 43, both the first and second total circumferential lengths differ from the third total circumferential length.
More desirably, at least one of the first and second total circumferential lengths is less than the third total circumferential length.
[01701 Adjacent serpentine circumferential bands may be connected by connectors extending from peaks to troughs, where the connectors are shorter in length than the bent struts. In the embodiment of Fig. 43, some of the peaks 106a and troughs 108a of adjacent serpentine circumferential bands 104 overlap one another and are joined one to the other. The overlapping peaks 1 06a and troughs 108a are longer than the remaining peaks 106 and troughs 108. The regions 130 of overlap between adjacent bands extend in a direction oblique to the longitudinal axis of the stent. The region may also extend in a circumferential direction or in a longitudinal direction. Examples of overlap regions 130 extending in these directions are shown in Figs. 30 and 38.
[01711 The invention is also directed to a stent such as that shown in Fig.
30, comprising a plurality of serpentine circumferential bands 104. Each serpentine circumferential band 104 comprises a plurality of peaks 106 and troughs 108 which are connected by bent struts 110. Adjacent serpentine circumferential bands are connected one to the other in one or more regions 130 of overlap where a peak 1 06a in one serpentine band overlaps with a trough 1 08a in an adjacent serpentine circumferential band. The one or more regions 130 of overlap extending in a longitudinal direction.
[0172] Optionally, at least one serpentine circumferential bands 104 will be of a greater total circumferential length than other of the serpentine circumferential bands 104. In the embodiment of Fig. 30, the proximal-most and distal-most serpentine circumferential bands 1 04a are of shorter total circumferential length than the remaining serpentine circumferential bands 104b of the stent.
[0173] The invention is also directed to a stent, as shown by way of example in Fig. 37, comprising a plurality of serpentine circumferential bands 104 where each serpentine circumferential band 104 comprises a plurality of peaks 106 and troughs 108. Adjacent peaks 106 and troughs 108 are connected by nested bent struts 110.
Serpentine circumferential bands 104 which are adjacent one another are connected via a plurality of connections 130. The stent includes two serpentine circumferential bands which are connected via a first number of connections and two serpentine circumferential bands which are connected via a second number of connections, where the second number is different from the first number.
[0174] The connections may be in the form of overlapping regions 130 of peaks 106a and troughs 108a on adjacent serpentine circumferential bands 104 or may be form of linear segments extending from one serpentine circumferential band to another serpentine circumferential band. An example of the latter connectors is shown in Fig. 25.
[01 75] Typically, the stent will have twice as many of the first number of connections as compared to the second number of connections. In the embodiment of Fig. 37, six connections are provided between the proximal-most serpentine circumferential band 104a and the serpentine circumferential band 1 04b adjacent thereto and six connections are provided between the distal-most serpentine circumferential band 104c and the serpentine circumferential band 1 04b adjacent thereto. The remainder of the adjacent serpentine circumferential bands 104b have three connections. Other numbers of connections are also within the scope of the invention. By way of example, the proximal-most serpentine circumferential band and the serpentine circumferential band adjacent thereto and/or the distal-most serpentine circumferential band and the serpentine circumferential band adjacent thereto may have four five, six or more connections and the remainder of the serpentine circumferential bands may have three connections.
[0176] The stents may optionally be constructed such that at least one of the proximal-most serpentine circumferential band and the distal-most serpentine circumferential band is of a different total circumferential length than other of the serpentine circumferential bands. Typically, the proximal-most and/or distal-most serpentine circumferential bands will be shorter in total circumferential length than the remaining bands. Moreover, the proximal-most serpentine circumferential band may be of a different total length than the distal-most serpentine circumferential band.
[0177] The invention is also directed to a stent such as that shown by way of example in Fig. 37 comprising a plurality of adjacent serpentine circumferential bands 104 containing alternating troughs 108 and peaks 106. Adjacent serpentine circumferential bands 104 have a plurality of cells 136 therebetween. At least two adjacent serpentine circumferential bands 104 have a plurality of first cells 1 36a therebetween and a plurality of second cells 136b therebetween. The second cells 1 36b are larger than the first cells 1 36a. Desirably the first and second cells 1 36a,b alternate with one another about the circumference of the stent. Optionally, as shown in Fig. 37, at least two adjacent serpentine circumferential bands 104 at the proximal end of the stent have a plurality of first cells 136a therebetween and a plurality of second cells 1 36b therebetween, the second cells 1 36b larger than the first cells 1 36a and at least two adjacent serpentine circumferential bands 104 at the distal end of the stent have a plurality of first cells 1 36a therebetween and a plurality of second cells 136b therebetween, the second cells 1 36b larger than the first cells 136a. Desirably, the second cells 1 36b are at least approximately twice the area of the first cells 1 36a. In the embodiment of Fig. 37, the first cells 1 36a are bounded at one end by one peak 106 and at another end by one trough 108.
[0178] In some embodiments of the invention, circumferentially adjacent struts are not parallel to one another. In the embodiments of Fig. 40 and 43, for example, as shown in inset A, bent struts 1 10 comprise first region 1 10a and second region 1 10b joined by elbow 1 10c. First region 1 10a is longer than second region 1 10b.
Each first region 1 10a is at an angle a (or 180 - a depending on whether first region inclines toward the distal end of the stent or declines toward the distal end of the stent) relative to the longitudinal axis of stent and each second second region 1 10b is at an angle 0 relative to the longitudinal axis of the stent (or 180 - P
depending on whether the second region declines toward the distal end of the stent or inclines toward the distal end of the stent). Elbow 1 10c subtends an angle y given by a - 0. Desirably, a and R are chosen such that elbow 1 10c subtends an angle y between about 5 degrees and 90 degrees.
[01 79] Each peak 104 of the stent has a first region 1 10a of one bent strut and a second region 1 10b of a second bent strut extending therefrom. First region 1 10a and second region 1 10b extending from the peak are non-parallel to one another.
Each trough 106 of the stent has a first region 1 10a of one bent strut and a second region 1 10b of a second bent strut extending therefrom. First region 1 10a and second region 1 10b extending from the trough are non-parallel to one another as well.
[0180] Because of the difference in length of the first and second regions and the angles of the first and second regions, adjacent inflection points 1 10d of elbows 1 10c on a given circumferential band are staggered slightly in a longitudinal direction as the circumference of the stent is traversed.
[01811 These features allow for improved crimpability of the stent.
[0182] Desirably, the angle y of the elbow regions of the inventive stents remains constant on expansion of the stent and is substantially the same in the expanded state as it is in the unexpanded state. This feature contributes to compression resistance of the stent.
[0183] The invention is also directed to a stent comprising a plurality of serpentine circumferential bands including a first serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by bent struts and a second serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by relatively straight struts. The first and second serpentine circumferential bands are connected to one another. Desirably, the first and second serpentine circumferential bands are connected one to the other via a plurality of connectors which optionally are straight and optionally non-parallel to the longitudinal axis of the stent. Typically, the connectors will extend from peaks on the first serpentine circumferential bands to peaks on the second serpentine circumferential band.
[0184] An example of such a stent is shown at 100 in Fig. 19. The stent of Fig.
19 comprises a plurality of the first serpentine circumferential bands and a plurality of the second serpentine circumferential bands where serpentine circumferential bands which are adjacent one another are connected one to the other. In the stent of Fig. 19. the first and second serpentine circumferential bands alternate with one another over the length of the stent.
[0185] Any of the inventive stents disclosed above may be provided with a uniform diameter or may taper in portions or along the entire length of the stent.
Also, the width and/or thickness of the various portions of the inventive stents may increase or decrease along a given portion of the stent. For example, the width and/or thickness of the circumferential bands and/or connectors may increase or decrease along portions of the stent or along the entire length of the stent.
The amplitude and wavelength of several successive first circumferential bands may remain constant while the width and/or thickness of the successive first circumferential bands decrease. Similarly, the amplitude and wavelength of several successive second circumferential bands may remain constant while the width and/or thickness of the successive second circumferential bands decrease.
[0186] The inventive stents may also be provided with end effects by modifying the stent such that that one or both ends are more rigid or more flexible than the remainder of the stent. Any of the inventive stents disclosed herein may be modified to have proximal-most and/or distal-most circumferential bands of a greater total circumferential length than the remaining circumferential bands. Any of the inventive stents disclosed herein may also be modified to have proximal-most and/or distal-most circumferential bands of a lesser total circumferential length than the remaining circumferential bands. Moreover, any of the inventive stents disclosed herein may also be modified so that one of the ends has circumferential bands of a lesser total circumferential length than the circumferential band of the other end which in turn is longer or shorter than the total length of any of the remaining circumferential bands.
[0187] Also, one or both of the end circumferential bands may be modified to be of a greater longitudinal extent than the remaining circumferential bands or to be of a lesser longitudinal extent than the remaining circumferential bands. Each of the two end circumferential bands may differ in longitudinal extent with one another and with the remaining circumferential bands.
[0188] The invention also contemplates modifying the ends of any of the inventive stents so that the two proximal-most and/or two distal-most circumferential bands have more connections therebetween than the remaining circumferential bands or fewer connections therebetween than the remaining circumferential bands.
[0189] Further, the proximal-most and/or distal-most circumferential bands may be of a greater mass than the remaining bands or a lower mass than the remaining bands. They may be thicker than the remaining bands or thinner than the remaining bands.
[0190] It is understood that the above discussed modifications resulting in end effects may be applied to multiple circumferential bands at one or both ends of the stent and are not limited to the proximal-most and distal-most circumferential bands.
[01911 The stents disclosed herein may also be modified by employing different types of connections between the circumferential bands. To that end, any of the connectors and connector configurations disclosed herein may be used in any of the disclosed embodiments. For example, in those embodiments in which adjacent circumferential bands overlap, the stent may be modified so that the adjacent circumferential bands do not overlap and are connected by connectors extending between the circumferential bands. Any of the connectors and connector configurations may be used. Other shaped connectors may also be used including those shown at 1 20a-i in Fig. 46. As shown in Fig. 46, the connectors may have one or more bends therein. The connectors may extend from peaks to troughs, from peaks to peaks, from troughs to peaks and/or from troughs to troughs. The connectors may be longer than the individual circumferential bands, which may, but need to occur with connectors with bends therein or they may be shorter than the individual segments.
[0192] The stents disclosed herein may also be modified by changing the number of connections between adjacent circumferential bands. Thus, where larger cells are desired, fewer connections between circumferential bands will be provided.
Where smaller cells are desired, more connections between bands will be provided.
Any of the embodiments shown may also be modified in some portions of the stent but not others. Thus, some sections of the stent may have more connections and other sections may have fewer connections. More flexibility may be achieved by providing fewer connections between adjacent circumferential bands.
[0193] The connectors may range in width from being wider than the width of the widest struts in the stent, to being narrower than the narrowest struts in the stent or anywhere in between. Regions of different flexibility may also be achieved by using wider connection in some regions, for example the one or both of the ends of the stent and narrower connectors in the other regions of the stent (e.g.
the middle) or vice versa.
[0194] The invention also contemplates embodiments in which the spacing between adjacent circumferential bands varies in different portions of the stent. For example, the proximal-most circumferential band and/or the distal-most circumferential band may be spaced further apart from the circumferential bands adjacent thereto or may be spaced closer thereto. This would result in using longer connectors between the end bands or shorter connectors, depending on the configuration. In one embodiment, both the proximal-most and the distal-most circumferential bands are more closely spaced to adjacent circumferential bands than the spacing between the remaining circumferential bands and further, the spacing between the proximal-most circumferential band and the circumferential band adjacent thereto differs from the spacing between the distal-most circumferential band and the circumferential band adjacent thereto.
[0195] It is also within the scope of the invention for any of the stent disclosed herein to have connectors extending from regions other than peaks and trough or corners of peaks and troughs. For example, the connectors may extend from positions midway between adjacent peaks and troughs, from position one quarter of the way between peaks and troughs, from positions three quarters of the way between peaks and troughs or anywhere else between peaks and troughs.
[0196] As shown in the various embodiments, the connections between circumferential bands may extend in a longitudinal direction or may have first and second ends which are circumferentially and longitudinally offset from one another, as in the case of connections extending at an oblique angle. The connections may also include portions which are non-parallel to the longitudinal axis of the stent.
[0197] The 'phase relationship' between adjacent circumferential bands may also be modified in any of the embodiments. For example, in embodiments of the invention such as that of Fig. 24, peaks of adjacent cylindrical bands may be in longitudinal alignment with one another or may be unaligned with one another in the longitudinal direction. Similarly, peaks on one band may be longitudinally aligned with troughs on an adjacent circumferential band or may be unaligned with troughs on an adjacent circumferential band. Some of the adjacent circumferential bands may be aligned while other adjacent bands may not be aligned.
[0198] Bent struts as referred to herein typically have two segments joined by a bent portion. The segments are straight as shown in the figures but may also be curved, The bent struts may be modified to have more than one bend. For example, a strut having three or more segments and two or more bends may also be used.
More generally, substantially bow shaped struts may be used.
[0199] The stent patterns disclosed herein may also be used for bifurcated stents. One or more legs and/or the trunk of a bifurcated stent may be provided with any of the stent designs disclosed herein.
[0200] The inventive stents may be manufactured using known stent manufacturing techniques. Suitable methods for manufacturing the inventive stents include laser cutting, chemical etching or stamping of a tube. The inventive stents may also be manufactured by laser cutting, chemically etching, stamping a flat sheet, rolling the sheet and, optionally, welding the sheet. Other suitable manufacturing techniques include electrode discharge machining or molding the stent with the desired design. The stent may also be manufactured by welding individual sections, for example, circumferential bands, together. Any other suitable stent manufacturing process may also be used.
[0201] Any suitable stent material may be used in the manufacture of the inventive stents. Examples of such materials include polymeric materials, metals, ceramics and composites. Suitable polymeric materials include thermotropic liquid crystal polymers (LCP's). Where the stent is made of metal, the metal may be stainless steel, cobalt chrome alloys such as elgiloy, tantalum or other plastically deformable metals. Other suitable metals include shape-memory metals such as nickel-titanium alloys generically known as "nitinol", platinum/tungsten alloys and titanium alloys.
[0202] The invention also contemplates the use of more than one material in the inventive stents. For example, the first undulating bands and the second undulating bands may be made of different materials. Optionally, the connectors may be made of a different material than the first and/or second undulating bands.
[0203] The inventive stents may be provided in mechanically expandable form, in self-expanding form or as a hybrid of the two. Mechanically expandable stents, in accordance with the invention, may be expanded using any suitable mechanical device including a balloon.
[0204] The inventive stents may include suitable radiopaque coatings. For example, the stents may be coated with gold or other noble metals or sputtered with tantalum or other metals. The stents may also be made directly from a radiopaque material to obviate the need for a radiopaque coating or may be made of a material having a radiopaque inner core. Other radiopaque metals which may be used include platinum, platinum-tungsten, palladium, platinum-iridium, rhodium, tantalum, or alloys or composites of these metals.
[0205] The inventive stents may also be provided with various bio-compatible coatings to enhance various properties of the stent. For example, the inventive stents may be provided with lubricious coatings. The inventive stents may also be provided with drug-containing coatings which release drugs over time. The increased surface area of a stent having bent struts provides for increased drug coatability. The bent struts also provide for point contact with a crimper versus strut/strut contact. Less contact with the crimper results in less disruption of the drug coating.
[0206] The inventive stents may also be provided with a sugar or more generally a carbohydrate and/or a gelatin to maintain the stent on a balloon during delivery of the stent to a desired bodily location. Other suitable compounds for treating the stent include biodegradable polymers and polymers which are dissolvable in bodily fluids. Portions of the interior and/or exterior of the stent may be coated or impregnated with the compound. Mechanical retention devices may also be used to maintain the stent on the balloon during delivery. To that end, the use of other coatings on the inventive stents is also within the scope of the invention.
[0207] The coating may comprise one or more non-genetic therapeutic agents, genetic materials and cells and combinations thereof as well as other polymeric coatings.
[0208] Non-genetic therapeutic agents include anti-thrombogenic agents such as heparin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chIoromethyl ketone); anti-proliferative agents such as enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, and acetylsalicylic acid; anti-inflammatory agents such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, and mesalamine; antineoplastic/antiproliferative/anti-miotic agents such as paclitaxel, 5-fluorouracil, cisplatin, vinblastine, vincristine, epothilones, endostatin, angiostatin and thymidine kinase inhibitors; anesthetic agents such as lidocaine, bupivacaine, and ropivacaine; anti-coagulants such as D-Phe-Pro-Arg chloromethyl keton, an RGD peptide-containing compound, heparin, antithrombin compounds, platelet receptor antagonists, anti-thrombin anticodies, anti-platelet receptor antibodies, aspirin, prostaglandin inhibitors, platelet inhibitors and tick antiplatelet peptides; vascular cell growth promotors such as growth factor inhibitors, growth factor receptor antagonists, transcriptional activators, and translational promotors;
vascular cell growth inhibitors such as growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin; cholesterol-lowering agents;
vasodilating agents; and agents which interfere with endogenous vascoactive mechanisms.
[0209] Genetic materials include anti-sense DNA and RNA, DNA coding for, anti-sense RNA, tRNA or rRNA to replace defective or deficient endogenous molecules, angiogenic factors including growth factors such as acidic and basic fibroblast growth factors, vascular endothelial growth factor, epidermal growth factor, transforming growth factor sand 0, platelet-derived endothelial growth factor, platelet-derived growth factor, tumor necrosis factor a, hepatocyte growth factor and insulin like growth factor, cell cycle inhibitors including CD inhibitors, thymidine kinase ("TK") and other agents useful for interfering with cell proliferation the family of bone morphogenic proteins ("BMP"s"),BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 (Vgr-1), BMP-7 (OP-1), BMP-8, BMP-9, BMP-10, BMP-1 1, BMP-12, BMP-13, BMP-14, BMP-
15, and BMP-16. Desirable BMP"s are any of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 and BMP-7. These dimeric proteins can be provided as homodimers, heterodimers, or combinations thereof, alone or together with other molecules. Alternatively or, in addition, molecules capable of inducing an upstream or downstream effect of a BMP
can be provided. Such molecules include any of the "hedgehog" proteins, or the DNA"s encoding them.
[0210] Cells can be of human origin (autologous or allogeneic) or from an animal source (xenogeneic), genetically engineered if desired to deliver proteins of interest at the transplant site. The cells may be provided in a delivery media. The delivery media may be formulated as needed to maintain cell function and viability.
[0211] Suitable polymer coating materials include polycarboxylic acids, cellulosic polymers, including cellulose acetate and cellulose nitrate, gelatin, polyvinylpyrrolidone, cross-linked polyvinylpyrrolidone, polyanhydrides including maleic anhydride polymers, polyamides, polyvinyl alcohols, copolymers of vinyl monomers such as EVA, polyvinyl ethers, polyvinyl aromatics, polyethylene oxides, glycosaminoglycans, polysaccharides, polyesters including polyethylene terephthalate, polyacrylamides, polyethers, polyether sulfone, polycarbonate, polyalkylenes including polypropylene, polyethylene and high molecular weight polyethylene, halogenated polyalkylenes including polytetrafluoroethylene, polyurethanes, polyorthoesters, proteins, polypeptides, silicones, siloxane polymers, polylactic acid, polyglycolic acid, polycaprolactone, polyhydroxybutyrate valerate and blends and copolymers thereof, coatings from polymer dispersions such as polyurethane dispersions (for example, BAYHDROL ), fibrin, collagen and derivatives thereof, polysaccharides such as celluloses, starches, dextrans, alginates and derivatives, hyaluronic acid, squalene emulsions. Polyacrylic acid, available as HYDROPLUS (Boston Scientific Corporation, Natick, Mass.), and described in U.S.
Pat. No. 5,091,205, the disclosure of which is hereby incorporated herein by reference, is particularly desirable. Even more desirable is a copolymer of polylactic acid and polycaprolactone.
[0212] The inventive stents may also be used as the framework for a graft.
Suitable coverings include nylon, collagen, PTFE and expanded PTFE, polyethylene terephthalate and KEVLAR, or any of the materials disclosed in US 5,824,046 and US
5,755,770. More generally, any known graft material may be used including synthetic polymers such as polyethylene, polypropylene, polyurethane, polyglycolic acid, polyesters, polyamides, their mixtures, blends and copolymers.
[0213] The inventive stents may find use in coronary arteries, renal arteries, peripheral arteries including iliac arteries, arteries of the neck and cerebral arteries.
The stents of the present invention, however, are not limited to use in the vascular = CA 02446358 2009-09-14 system and may also be advantageously employed in other body structures, including but not limited to arteries, veins, biliary ducts, urethras, fallopian tubes, bronchial tubes, the trachea, the esophagus, the prostate and the bowels.
[0214] Suitable stent delivery devices such as those disclosed in US
6,123,712, US
6,120,522 and US 5,957,930 may be used to deliver the inventive stents to the desired bodily location. The choice of delivery device will depend on whether a self-expanding or balloon expandable stent is used. The inventive stents may be delivered in conjunction with one or more stent retaining sleeves. An example of stent retaining sleeves is disclosed in US
7,001,419.
[0215] The invention is also directed to a stent having a flowpath therethrough, where the flowpath defines a longitudinal direction. The stent comprises a plurality of serpentine circumferential bands including a first serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs of the first circumferential band connected by bent struts, and a second serpentine band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by bent struts, each bent strut having only a single bend. Some of the peaks of the first serpentine circumferential band overlap with some of the troughs of the second serpentine circumferential band in regions of overlap. An example of such a stent is shown in Fig. 27.
[0216] Each region of overlap may extend in a direction parallel to the longitudinal direction (Fig. 30), perpendicular to the longitudinal direction (Fig. 27) or diagonal to the longitudinal direction (fig. 32).
[0217] Desirably, as shown, for example, in Fig. 26, the peaks of the first serpentine circumferential band and the troughs of the first serpentine circumferential band point in different directions relative to the longitudinal direction.
[0218] Also, desirably, the peaks of the first serpentine circumferential band point in different directions from the peaks of the second serpentine circumferential band and the troughs of the first serpentine circumferential band point in different directions from the troughs of the second serpentine circumferential band.
[0219] Further, as shown by way of example in Fig. 40, each bent strut may include two straight portions, including a first portion and a second portion, at least some of the bent struts characterized by a first portion which is longer than the second portion of the bent strut.
[0220] Optionally, the bends in circumferentially adjacent bent struts are offset in a longitudinal direction relative to one another, as shown in Fig. 45 and 45a.
= CA 02446358 2009-09-14 [0221] Typically the stent will comprise a plurality of first serpentine circumferential bands and second serpentine circumferential bands, the first and second serpentine circumferential bands alternating along the length of the stent. Some of the peaks of the first serpentine circumferential bands overlap some of the troughs of the second serpentine circumferential bands.
[0222] The invention is also directed to a stent comprising a plurality of cells, the cells having distal and proximal ends and comprising a plurality of bent finger portions at the proximal end which bend in a first direction and a plurality of finger portions at the distal end which bend in a second direction opposite to the first portion where circumferentially adjacent cells connected one to the other via a short connector.
[0223] The short connector may extend in a circumferential direction, in a longitudinal direction or a diagonal direction.
[0224] Desirably, each cell has three troughs at a proximal end and three peaks at a distal end.
[0225] Some of the bent finger portions may be narrower than others of the bent finger portions.
[0226] While reference has been made to various preferred embodiments of the invention other variations are comprehended by the broad scope of the appended claims.
Some of these have been discussed in detail in this specification and others will be apparent to those skilled in the art. All such variations and alterations are comprehended by this specification are intended to be covered, without limitation.
can be provided. Such molecules include any of the "hedgehog" proteins, or the DNA"s encoding them.
[0210] Cells can be of human origin (autologous or allogeneic) or from an animal source (xenogeneic), genetically engineered if desired to deliver proteins of interest at the transplant site. The cells may be provided in a delivery media. The delivery media may be formulated as needed to maintain cell function and viability.
[0211] Suitable polymer coating materials include polycarboxylic acids, cellulosic polymers, including cellulose acetate and cellulose nitrate, gelatin, polyvinylpyrrolidone, cross-linked polyvinylpyrrolidone, polyanhydrides including maleic anhydride polymers, polyamides, polyvinyl alcohols, copolymers of vinyl monomers such as EVA, polyvinyl ethers, polyvinyl aromatics, polyethylene oxides, glycosaminoglycans, polysaccharides, polyesters including polyethylene terephthalate, polyacrylamides, polyethers, polyether sulfone, polycarbonate, polyalkylenes including polypropylene, polyethylene and high molecular weight polyethylene, halogenated polyalkylenes including polytetrafluoroethylene, polyurethanes, polyorthoesters, proteins, polypeptides, silicones, siloxane polymers, polylactic acid, polyglycolic acid, polycaprolactone, polyhydroxybutyrate valerate and blends and copolymers thereof, coatings from polymer dispersions such as polyurethane dispersions (for example, BAYHDROL ), fibrin, collagen and derivatives thereof, polysaccharides such as celluloses, starches, dextrans, alginates and derivatives, hyaluronic acid, squalene emulsions. Polyacrylic acid, available as HYDROPLUS (Boston Scientific Corporation, Natick, Mass.), and described in U.S.
Pat. No. 5,091,205, the disclosure of which is hereby incorporated herein by reference, is particularly desirable. Even more desirable is a copolymer of polylactic acid and polycaprolactone.
[0212] The inventive stents may also be used as the framework for a graft.
Suitable coverings include nylon, collagen, PTFE and expanded PTFE, polyethylene terephthalate and KEVLAR, or any of the materials disclosed in US 5,824,046 and US
5,755,770. More generally, any known graft material may be used including synthetic polymers such as polyethylene, polypropylene, polyurethane, polyglycolic acid, polyesters, polyamides, their mixtures, blends and copolymers.
[0213] The inventive stents may find use in coronary arteries, renal arteries, peripheral arteries including iliac arteries, arteries of the neck and cerebral arteries.
The stents of the present invention, however, are not limited to use in the vascular = CA 02446358 2009-09-14 system and may also be advantageously employed in other body structures, including but not limited to arteries, veins, biliary ducts, urethras, fallopian tubes, bronchial tubes, the trachea, the esophagus, the prostate and the bowels.
[0214] Suitable stent delivery devices such as those disclosed in US
6,123,712, US
6,120,522 and US 5,957,930 may be used to deliver the inventive stents to the desired bodily location. The choice of delivery device will depend on whether a self-expanding or balloon expandable stent is used. The inventive stents may be delivered in conjunction with one or more stent retaining sleeves. An example of stent retaining sleeves is disclosed in US
7,001,419.
[0215] The invention is also directed to a stent having a flowpath therethrough, where the flowpath defines a longitudinal direction. The stent comprises a plurality of serpentine circumferential bands including a first serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs of the first circumferential band connected by bent struts, and a second serpentine band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by bent struts, each bent strut having only a single bend. Some of the peaks of the first serpentine circumferential band overlap with some of the troughs of the second serpentine circumferential band in regions of overlap. An example of such a stent is shown in Fig. 27.
[0216] Each region of overlap may extend in a direction parallel to the longitudinal direction (Fig. 30), perpendicular to the longitudinal direction (Fig. 27) or diagonal to the longitudinal direction (fig. 32).
[0217] Desirably, as shown, for example, in Fig. 26, the peaks of the first serpentine circumferential band and the troughs of the first serpentine circumferential band point in different directions relative to the longitudinal direction.
[0218] Also, desirably, the peaks of the first serpentine circumferential band point in different directions from the peaks of the second serpentine circumferential band and the troughs of the first serpentine circumferential band point in different directions from the troughs of the second serpentine circumferential band.
[0219] Further, as shown by way of example in Fig. 40, each bent strut may include two straight portions, including a first portion and a second portion, at least some of the bent struts characterized by a first portion which is longer than the second portion of the bent strut.
[0220] Optionally, the bends in circumferentially adjacent bent struts are offset in a longitudinal direction relative to one another, as shown in Fig. 45 and 45a.
= CA 02446358 2009-09-14 [0221] Typically the stent will comprise a plurality of first serpentine circumferential bands and second serpentine circumferential bands, the first and second serpentine circumferential bands alternating along the length of the stent. Some of the peaks of the first serpentine circumferential bands overlap some of the troughs of the second serpentine circumferential bands.
[0222] The invention is also directed to a stent comprising a plurality of cells, the cells having distal and proximal ends and comprising a plurality of bent finger portions at the proximal end which bend in a first direction and a plurality of finger portions at the distal end which bend in a second direction opposite to the first portion where circumferentially adjacent cells connected one to the other via a short connector.
[0223] The short connector may extend in a circumferential direction, in a longitudinal direction or a diagonal direction.
[0224] Desirably, each cell has three troughs at a proximal end and three peaks at a distal end.
[0225] Some of the bent finger portions may be narrower than others of the bent finger portions.
[0226] While reference has been made to various preferred embodiments of the invention other variations are comprehended by the broad scope of the appended claims.
Some of these have been discussed in detail in this specification and others will be apparent to those skilled in the art. All such variations and alterations are comprehended by this specification are intended to be covered, without limitation.
Claims (21)
PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A stent comprising a plurality of serpentine circumferential bands, each serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by bent struts, each bent strut having a single bend, adjacent serpentine circumferential bands connected one to the other in one or more regions of overlap where at least some, but not all, of the plurality of peaks of one serpentine band overlap some, but not all, of the plurality of troughs in an adjacent serpentine circumferential band, the one or more regions of overlap extending in a longitudinal direction.
2. The stent of claim 1 wherein at least one serpentine circumferential bands is of a greater total circumferential length than other of the serpentine circumferential bands.
3. A stent having a flowpath therethrough, the flowpath defining a longitudinal direction, the stent comprising a plurality of serpentine circumferential bands including a first serpentine circumferential band comprising a plurality of peaks and troughs, adjacent peaks and troughs of the first circumferential band connected by bent struts, and a second serpentine band comprising a plurality of peaks and troughs, adjacent peaks and troughs connected by bent struts, each bent strut having only a single bend, only some of the peaks of the first serpentine circumferential band overlapping with some of the troughs of the second serpentine circumferential band in regions of overlap.
4. The stent of claim 3 wherein each region of overlap extends in a direction parallel to the longitudinal direction.
5. The stent of claim 3 wherein each region of overlap extends in a direction perpendicular to the longitudinal direction.
6. The stent of claim 3 wherein each region of overlap extends in a diagonal direction relative to the longitudinal direction.
7. The stent of claim 6 wherein the peaks of the first serpentine circumferential band and the troughs of the first serpentine circumferential band point in different directions relative to the longitudinal direction.
8. The stent of claim 7 wherein the peaks of the second serpentine circumferential band and the troughs of the second serpentine circumferential band point in different directions relative to the longitudinal direction.
9. The stent of claim 8 wherein the peaks of the first serpentine circumferential band point in different directions from the peaks of the second serpentine circumferential band and the troughs of the first serpentine circumferential band point in different directions from the troughs of the second serpentine circumferential band.
10. The stent of claim 3 wherein the peaks of the first serpentine circumferential band point in different directions from the peaks of the second serpentine circumferential band and the troughs of the first serpentine circumferential band point in different directions from the troughs of the second serpentine circumferential band.
11. The stent of claim 3 wherein each bent strut includes two straight portions, including a first portion and a second portion, at least some of the bent struts characterized by a first portion which is longer than the second portion, of the bent strut.
12. The stent of claim 8 wherein each bent strut includes two straight portions, including a first portion and a second portion, at least some of the bent struts characterized by a first portion which is longer than the second portion of the bent strut.
13. The stent of claim 11 wherein the bends in circumferentially adjacent bent struts are offset in a longitudinal direction relative to one another.
14. The stent of claim 3 wherein the bends in circumferentially adjacent bent struts are offset in a longitudinal direction relative to one another.
15. The stent of claim 3 comprising a plurality of first serpentine circumferential bands and second serpentine circumferential bands, the first and second serpentine circumferential bands alternating along the length of the stent, some of the peaks of the first serpentine circumferential bands overlapping some of the troughs of the second serpentine circumferential bands.
16. The stent of claim 15 wherein each region of overlap extends in a direction parallel to the longitudinal direction.
17. The stent of claim 15 wherein each region of overlap extends in a direction perpendicular to the longitudinal direction.
18. The stent of claim 15 wherein each region of overlap extends in a diagonal direction relative to the longitudinal direction.
19. The stent of claim 15 wherein the peaks of the first serpentine circumferential bands point in different directions from the peaks of the second serpentine circumferential bands and the troughs of the first serpentine circumferential bands point in different directions from the troughs of the second serpentine circumferential bands.
20. The stent of claim 16 wherein the peaks of the first serpentine circumferential bands point in different directions from the peaks of the second serpentine circumferential bands and the troughs of the first serpentine circumferential bands point in different directions from the troughs of the second serpentine circumferential bands.
21. The stent of claim 17 wherein the peaks of the first serpentine circumferential bands point in different directions from the peaks of the second serpentine circumferential bands and the troughs of the first serpentine circumferential bands point in different directions from the troughs of the second serpentine circumferential bands.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/063,179 | 2002-03-28 | ||
US10/063,179 US8070792B2 (en) | 2000-09-22 | 2002-03-28 | Stent |
PCT/US2003/009716 WO2003082154A2 (en) | 2002-03-28 | 2003-03-27 | Improved stent |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2446358A1 CA2446358A1 (en) | 2003-10-09 |
CA2446358C true CA2446358C (en) | 2011-05-10 |
Family
ID=28673434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2446358A Expired - Fee Related CA2446358C (en) | 2002-03-28 | 2003-03-27 | Improved stent |
Country Status (13)
Country | Link |
---|---|
US (2) | US8070792B2 (en) |
EP (3) | EP2044908A1 (en) |
JP (3) | JP2005521472A (en) |
KR (1) | KR20040104298A (en) |
CN (1) | CN1545400A (en) |
AT (2) | ATE337755T1 (en) |
AU (1) | AU2003218461A1 (en) |
BR (1) | BR0303669A (en) |
CA (1) | CA2446358C (en) |
DE (2) | DE60307976T2 (en) |
IL (1) | IL158834A0 (en) |
MX (1) | MXPA03010848A (en) |
WO (1) | WO2003082154A2 (en) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US20070073384A1 (en) | 1995-03-01 | 2007-03-29 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US20060173531A1 (en) * | 1996-09-19 | 2006-08-03 | Jacob Richter | Stent with variable features to optimize support and method of making such stent |
US5807404A (en) | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US7341598B2 (en) | 1999-01-13 | 2008-03-11 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7329277B2 (en) * | 1997-06-13 | 2008-02-12 | Orbusneich Medical, Inc. | Stent having helical elements |
EP0884029B1 (en) * | 1997-06-13 | 2004-12-22 | Gary J. Becker | Expandable intraluminal endoprosthesis |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US7101391B2 (en) * | 2000-09-18 | 2006-09-05 | Inflow Dynamics Inc. | Primarily niobium stent |
US7144420B2 (en) * | 2002-03-14 | 2006-12-05 | Boston Scientific Scimed, Inc. | Segmented spine |
EP1507494A2 (en) * | 2002-05-06 | 2005-02-23 | Abbott Laboratories | Endoprosthesis for controlled contraction and expansion |
JP2005524488A (en) * | 2002-05-08 | 2005-08-18 | アボット・ラボラトリーズ | Endoprosthesis with extended foot |
US7223283B2 (en) * | 2002-10-09 | 2007-05-29 | Boston Scientific Scimed, Inc. | Stent with improved flexibility |
US6932930B2 (en) * | 2003-03-10 | 2005-08-23 | Synecor, Llc | Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same |
US7625401B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7625398B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7112216B2 (en) * | 2003-05-28 | 2006-09-26 | Boston Scientific Scimed, Inc. | Stent with tapered flexibility |
US20050149168A1 (en) * | 2003-12-30 | 2005-07-07 | Daniel Gregorich | Stent to be deployed on a bend |
US8454676B1 (en) | 2004-01-20 | 2013-06-04 | Advanced Cardiovascular Systems, Inc. | Transition matching stent |
US8049137B2 (en) * | 2004-02-13 | 2011-11-01 | Boston Scientific Scimed, Inc. | Laser shock peening of medical devices |
US20050182474A1 (en) * | 2004-02-13 | 2005-08-18 | Medtronic Vascular, Inc. | Coated stent having protruding crowns and elongated struts |
DE102004012981B4 (en) | 2004-03-16 | 2009-01-02 | Alveolus Inc. | stent |
DE602004022461D1 (en) * | 2004-05-05 | 2009-09-17 | Invatec Srl | Endoluminalprothese |
WO2005122959A2 (en) | 2004-06-08 | 2005-12-29 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US9427340B2 (en) | 2004-12-14 | 2016-08-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US9586030B2 (en) * | 2004-12-23 | 2017-03-07 | Boston Scientific Scimed, Inc. | Fugitive plasticizer balloon surface treatment for enhanced stent securement |
US7651524B2 (en) | 2005-03-30 | 2010-01-26 | Terumo Kabushiki Kaisha | Flexible stent |
JP4928813B2 (en) * | 2005-03-30 | 2012-05-09 | テルモ株式会社 | In-vivo stent |
JP4928891B2 (en) * | 2006-09-29 | 2012-05-09 | テルモ株式会社 | Self-expanding in-vivo stent |
ES2340864T3 (en) * | 2005-03-30 | 2010-06-10 | Terumo Kabushiki Kaisha | CANULA |
US8628565B2 (en) * | 2005-04-13 | 2014-01-14 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
WO2006124824A1 (en) | 2005-05-13 | 2006-11-23 | Alveolus, Inc. | Drainage stent and associated method |
EP2364676B1 (en) | 2005-06-30 | 2018-12-19 | Abbott Laboratories | Endoprosthesis having foot extensions |
US20070050011A1 (en) * | 2005-08-26 | 2007-03-01 | Medlogics Device Corporation | Lumen-supporting stents and methods for creating lumen-supporting stents with various open/closed designs |
WO2007040250A1 (en) * | 2005-10-05 | 2007-04-12 | Kaneka Corporation | Stent to be placed in the living body |
US7404823B2 (en) | 2005-10-31 | 2008-07-29 | Boston Scientific Scimed, Inc. | Stent configurations |
JP2007117548A (en) * | 2005-10-31 | 2007-05-17 | Japan Stent Technology Co Ltd | Stent |
US7540881B2 (en) | 2005-12-22 | 2009-06-02 | Boston Scientific Scimed, Inc. | Bifurcation stent pattern |
US7381217B2 (en) * | 2005-12-23 | 2008-06-03 | Boston Scientific Scimed, Inc. | Serpentine stent pattern |
US8348991B2 (en) * | 2006-03-29 | 2013-01-08 | Boston Scientific Scimed, Inc. | Stent with overlap and high expansion |
US8043358B2 (en) * | 2006-03-29 | 2011-10-25 | Boston Scientific Scimed, Inc. | Stent with overlap and high extension |
US8414637B2 (en) * | 2006-09-08 | 2013-04-09 | Boston Scientific Scimed, Inc. | Stent |
US7988720B2 (en) | 2006-09-12 | 2011-08-02 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US7951191B2 (en) | 2006-10-10 | 2011-05-31 | Boston Scientific Scimed, Inc. | Bifurcated stent with entire circumferential petal |
US7842082B2 (en) | 2006-11-16 | 2010-11-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US7959669B2 (en) | 2007-09-12 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent with open ended side branch support |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
JP2010540190A (en) | 2007-10-04 | 2010-12-24 | トリバスキュラー・インコーポレイテッド | Modular vascular graft for low profile transdermal delivery |
US20100298926A1 (en) * | 2007-10-16 | 2010-11-25 | Kabushikikaisha Kyoto Iryo Sekkei | Cylindrically-shaped element for luminal stent, and luminal stent |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
US7833266B2 (en) | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
US8277501B2 (en) | 2007-12-21 | 2012-10-02 | Boston Scientific Scimed, Inc. | Bi-stable bifurcated stent petal geometry |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US8932340B2 (en) | 2008-05-29 | 2015-01-13 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
CN104188742B (en) | 2009-04-10 | 2018-01-19 | 泰科保健集团有限合伙公司 | Implant with high antifatigue, implant induction system and application method |
EP2429453B1 (en) * | 2009-05-14 | 2021-01-27 | Orbusneich Medical Pte. Ltd | Self-expanding stent with polygon transition zone |
US8366765B2 (en) * | 2009-09-18 | 2013-02-05 | Medtronic Vascular, Inc. | Helical stent with connections |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
WO2011097098A1 (en) | 2010-02-03 | 2011-08-11 | Boston Scientific Scimed, Inc. | A therapeutic balloon with systemic drug loss protection and controlled particle size release |
US8206434B2 (en) | 2010-03-02 | 2012-06-26 | Medtronic Vascular, Inc. | Stent with sinusoidal wave form and orthogonal end and method for making same |
US20110218615A1 (en) * | 2010-03-02 | 2011-09-08 | Medtronic Vascular, Inc. | Stent With Multi-Crown Constraint and Method for Ending Helical Wound Stents |
US8882824B2 (en) * | 2010-04-20 | 2014-11-11 | Cg Bio Co., Ltd. | Expanding vascular stent |
US8328072B2 (en) | 2010-07-19 | 2012-12-11 | Medtronic Vascular, Inc. | Method for forming a wave form used to make wound stents |
BR112013002700B1 (en) * | 2010-08-02 | 2020-12-15 | Cardinal Health 529, Llc | FLEXIBLE HELICOIDAL STENT THAT HAS DIFFERENT HELICOIDAL REGIONS |
WO2012091770A1 (en) * | 2010-12-28 | 2012-07-05 | Boston Scientific Scimed, Inc. | Stent |
EP2658484A1 (en) | 2010-12-30 | 2013-11-06 | Boston Scientific Scimed, Inc. | Multi stage opening stent designs |
EP2680797B1 (en) | 2011-03-03 | 2016-10-26 | Boston Scientific Scimed, Inc. | Low strain high strength stent |
WO2012119037A1 (en) | 2011-03-03 | 2012-09-07 | Boston Scientific Scimed, Inc. | Stent with reduced profile |
CN102824237B (en) * | 2011-06-13 | 2015-12-09 | 北京华脉泰科医疗器械有限公司 | A kind of thoracic aorta covered bracket |
US9296034B2 (en) | 2011-07-26 | 2016-03-29 | Medtronic Vascular, Inc. | Apparatus and method for forming a wave form for a stent from a wire |
CN104159544B (en) * | 2012-03-07 | 2017-05-24 | 奥巴斯尼茨医学公司 | Medical device for implantation into luminal structures |
US9242290B2 (en) | 2012-04-03 | 2016-01-26 | Medtronic Vascular, Inc. | Method and apparatus for creating formed elements used to make wound stents |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
US9238260B2 (en) | 2012-04-18 | 2016-01-19 | Medtronic Vascular, Inc. | Method and apparatus for creating formed elements used to make wound stents |
US9364351B2 (en) | 2012-04-23 | 2016-06-14 | Medtronic Vascular, Inc. | Method for forming a stent |
US9066825B2 (en) | 2012-05-14 | 2015-06-30 | C.R. Bard, Inc. | Uniformly expandable stent |
USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
KR200485824Y1 (en) | 2017-03-14 | 2018-03-02 | (주)거성패브릭 | Elastic textile fabric |
EP3708129A1 (en) * | 2019-03-15 | 2020-09-16 | Biotronik Ag | Implant |
CN114948362A (en) * | 2021-02-16 | 2022-08-30 | 奥林巴斯株式会社 | Support frame |
Family Cites Families (194)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2836181A (en) * | 1955-01-17 | 1958-05-27 | Chemstrand Corp | Flexible nylon tube and method for preparing same |
US3105492A (en) * | 1958-10-01 | 1963-10-01 | Us Catheter & Instr Corp | Synthetic blood vessel grafts |
US3272204A (en) * | 1965-09-22 | 1966-09-13 | Ethicon Inc | Absorbable collagen prosthetic implant with non-absorbable reinforcing strands |
GB1104680A (en) * | 1965-10-18 | 1968-02-28 | Univ Birmingham | Artificial artery |
AT261800B (en) | 1966-08-22 | 1968-05-10 | Braun Internat Gmbh B | Process for the manufacture of tubular, smooth or threaded tissue-blood vessel prostheses |
US3509883A (en) * | 1967-11-29 | 1970-05-05 | Gen Electric | Expanding cannula |
US3526820A (en) * | 1968-06-14 | 1970-09-01 | Int Steel Co | Quarterline stop position control circuit for power driven revolving doors utilizing two speeds |
US3526228A (en) * | 1969-03-24 | 1970-09-01 | Ethicon Inc | Collagen lamina dural prosthesis |
US3635215A (en) * | 1969-08-14 | 1972-01-18 | Gam Rad | Medical removal hook |
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3771526A (en) * | 1972-02-07 | 1973-11-13 | P Rudie | Anastomosis clamp |
US3868956A (en) * | 1972-06-05 | 1975-03-04 | Ralph J Alfidi | Vessel implantable appliance and method of implanting it |
SE397769B (en) * | 1974-11-04 | 1977-11-21 | Gambro Ab | INITIATIVE ELEMENTS FOR USE IN VEHICLE SURGERY AND METHODS OF PRODUCING SUCCESSFUL |
GB1591793A (en) * | 1976-10-25 | 1981-06-24 | Welding Inst | Laser welding |
US4078167A (en) * | 1977-02-09 | 1978-03-07 | United Technologies Corporation | Welding shield and plasma suppressor apparatus |
US4140126A (en) * | 1977-02-18 | 1979-02-20 | Choudhury M Hasan | Method for performing aneurysm repair |
US4141364A (en) * | 1977-03-18 | 1979-02-27 | Jorge Schultze | Expandable endotracheal or urethral tube |
AU516741B2 (en) * | 1978-05-23 | 1981-06-18 | Bio Nova Neo Technics Pty. Ltd. | Vascular prostheses |
WO1980000007A1 (en) * | 1978-06-02 | 1980-01-10 | A Rockey | Medical sleeve |
US4214587A (en) * | 1979-02-12 | 1980-07-29 | Sakura Chester Y Jr | Anastomosis device and method |
US4300244A (en) * | 1979-09-19 | 1981-11-17 | Carbomedics, Inc. | Cardiovascular grafts |
JPS6028434Y2 (en) * | 1980-06-16 | 1985-08-28 | 建部 容保 | Artificial blood vessel |
US4441215A (en) * | 1980-11-17 | 1984-04-10 | Kaster Robert L | Vascular graft |
AU8954282A (en) * | 1981-09-16 | 1983-04-08 | Wallsten, H.I. | Device for application in blood vessels or other difficultly accessible locations and its use |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4470407A (en) * | 1982-03-11 | 1984-09-11 | Laserscope, Inc. | Endoscopic device |
US4413629A (en) * | 1982-04-22 | 1983-11-08 | Cryomedics, Inc. | Portable ultrasonic Doppler System |
SE445884B (en) * | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
DE3221425A1 (en) * | 1982-06-07 | 1983-12-08 | Boehringer Ingelheim KG, 6507 Ingelheim | HYDROLYSIS-SENSITIVE ACTIVE SUBSTANCE CONTAINING STORAGE TABLET |
US4597389A (en) * | 1982-09-30 | 1986-07-01 | Ibrahim Adel A | Device for removing objects from tubular body passages |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4503569A (en) * | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4550447A (en) * | 1983-08-03 | 1985-11-05 | Shiley Incorporated | Vascular graft prosthesis |
US4647416A (en) * | 1983-08-03 | 1987-03-03 | Shiley Incorporated | Method of preparing a vascular graft prosthesis |
US4560374A (en) * | 1983-10-17 | 1985-12-24 | Hammerslag Julius G | Method for repairing stenotic vessels |
US4535770A (en) * | 1983-11-02 | 1985-08-20 | Lemole Gerald M | Cardiovascular tourniquet |
US5104399A (en) * | 1986-12-10 | 1992-04-14 | Endovascular Technologies, Inc. | Artificial graft and implantation method |
US4787899A (en) * | 1983-12-09 | 1988-11-29 | Lazarus Harrison M | Intraluminal graft device, system and method |
US4655776A (en) * | 1984-01-12 | 1987-04-07 | Oto Enterprises, Inc. | Prostheses for ossicular reconstruction |
US4842575A (en) * | 1984-01-30 | 1989-06-27 | Meadox Medicals, Inc. | Method for forming impregnated synthetic vascular grafts |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
CA1264674A (en) * | 1984-10-17 | 1990-01-23 | Paul Ducheyne | Porous flexible metal fiber material for surgical implantation |
SE450809B (en) * | 1985-04-10 | 1987-08-03 | Medinvent Sa | PLANT TOPIC PROVIDED FOR MANUFACTURING A SPIRAL SPRING SUITABLE FOR TRANSLUMINAL IMPLANTATION AND MANUFACTURED SPIRAL SPRINGS |
SE447061B (en) * | 1985-06-10 | 1986-10-27 | Medinvent Sa | INFO DEVICE, SPEC FOR IMPLEMENTATION IN A LIVE ORGANISM |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
DE3640745A1 (en) * | 1985-11-30 | 1987-06-04 | Ernst Peter Prof Dr M Strecker | Catheter for producing or extending connections to or between body cavities |
US4681110A (en) * | 1985-12-02 | 1987-07-21 | Wiktor Dominik M | Catheter arrangement having a blood vessel liner, and method of using it |
US4851009A (en) * | 1985-12-16 | 1989-07-25 | Corvita Corporation | Crack prevention of implanted prostheses |
US4665918A (en) * | 1986-01-06 | 1987-05-19 | Garza Gilbert A | Prosthesis system and method |
US4649922A (en) * | 1986-01-23 | 1987-03-17 | Wiktor Donimik M | Catheter arrangement having a variable diameter tip and spring prosthesis |
US4878906A (en) * | 1986-03-25 | 1989-11-07 | Servetus Partnership | Endoprosthesis for repairing a damaged vessel |
US4740207A (en) * | 1986-09-10 | 1988-04-26 | Kreamer Jeffry W | Intralumenal graft |
SE455834B (en) * | 1986-10-31 | 1988-08-15 | Medinvent Sa | DEVICE FOR TRANSLUMINAL IMPLANTATION OF A PRINCIPLE RODFORMALLY RADIALLY EXPANDABLE PROSTHESIS |
US4762128A (en) * | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4795465A (en) * | 1987-05-14 | 1989-01-03 | Hood Laboratories | Tracheobronchial stent |
US4872874A (en) * | 1987-05-29 | 1989-10-10 | Taheri Syde A | Method and apparatus for transarterial aortic graft insertion and implantation |
US4769029A (en) * | 1987-06-19 | 1988-09-06 | Patel Jayendrakumar I | Prosthetic graft for arterial system repair |
US5059211A (en) * | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
US4795458A (en) * | 1987-07-02 | 1989-01-03 | Regan Barrie F | Stent for use following balloon angioplasty |
US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US4886062A (en) * | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US4820298A (en) * | 1987-11-20 | 1989-04-11 | Leveen Eric G | Internal vascular prosthesis |
JP2561853B2 (en) * | 1988-01-28 | 1996-12-11 | 株式会社ジェイ・エム・エス | Shaped memory molded article and method of using the same |
US4877030A (en) * | 1988-02-02 | 1989-10-31 | Andreas Beck | Device for the widening of blood vessels |
US4830003A (en) * | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
US5092877A (en) * | 1988-09-01 | 1992-03-03 | Corvita Corporation | Radially expandable endoprosthesis |
US5019090A (en) * | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5226913A (en) | 1988-09-01 | 1993-07-13 | Corvita Corporation | Method of making a radially expandable prosthesis |
US5108415A (en) | 1988-10-04 | 1992-04-28 | Cordis Corporation | Balloons for medical devices and fabrication thereof |
CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
US4913141A (en) * | 1988-10-25 | 1990-04-03 | Cordis Corporation | Apparatus and method for placement of a stent within a subject vessel |
US4950227A (en) * | 1988-11-07 | 1990-08-21 | Boston Scientific Corporation | Stent delivery system |
US4856516A (en) * | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
US5091205A (en) * | 1989-01-17 | 1992-02-25 | Union Carbide Chemicals & Plastics Technology Corporation | Hydrophilic lubricious coatings |
US5147400A (en) | 1989-05-10 | 1992-09-15 | United States Surgical Corporation | Connective tissue prosthesis |
US4994071A (en) * | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US5037392A (en) * | 1989-06-06 | 1991-08-06 | Cordis Corporation | Stent-implanting balloon assembly |
US5015253A (en) * | 1989-06-15 | 1991-05-14 | Cordis Corporation | Non-woven endoprosthesis |
US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
CA2026604A1 (en) * | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Articulated stent |
US5035706A (en) * | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
US5147385A (en) | 1989-11-01 | 1992-09-15 | Schneider (Europe) A.G. | Stent and catheter for the introduction of the stent |
US5158548A (en) | 1990-04-25 | 1992-10-27 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5064435A (en) * | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5122154A (en) | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
US5139480A (en) | 1990-08-22 | 1992-08-18 | Biotech Laboratories, Inc. | Necking stents |
US5163952A (en) | 1990-09-14 | 1992-11-17 | Michael Froix | Expandable polymeric stent with memory and delivery apparatus and method |
US5108417A (en) * | 1990-09-14 | 1992-04-28 | Interface Biomedical Laboratories Corp. | Anti-turbulent, anti-thrombogenic intravascular stent |
US5344425A (en) | 1990-09-14 | 1994-09-06 | Interface Biomedical Laboratories, Corp. | Intravascular stent and method for conditioning the surfaces thereof |
DE9117152U1 (en) | 1990-10-09 | 1996-07-11 | Cook Inc | Stent |
US5217483A (en) | 1990-11-28 | 1993-06-08 | Numed, Inc. | Intravascular radially expandable stent |
US5135536A (en) | 1991-02-05 | 1992-08-04 | Cordis Corporation | Endovascular stent and method |
US5197978B1 (en) | 1991-04-26 | 1996-05-28 | Advanced Coronary Tech | Removable heat-recoverable tissue supporting device |
US5304200A (en) | 1991-05-29 | 1994-04-19 | Cordis Corporation | Welded radially expandable endoprosthesis and the like |
US5354309A (en) | 1991-10-11 | 1994-10-11 | Angiomed Ag | Apparatus for widening a stenosis in a body cavity |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
FR2683449A1 (en) | 1991-11-08 | 1993-05-14 | Cardon Alain | ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION. |
US5405377A (en) | 1992-02-21 | 1995-04-11 | Endotech Ltd. | Intraluminal stent |
US5282823A (en) | 1992-03-19 | 1994-02-01 | Medtronic, Inc. | Intravascular radially expandable stent |
US5540712A (en) | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5354308A (en) | 1992-05-01 | 1994-10-11 | Beth Israel Hospital Association | Metal wire stent |
US5465011A (en) * | 1992-12-14 | 1995-11-07 | Square D Company | Uninterruptible power supply with improved output regulation |
GR1002388B (en) | 1993-01-06 | 1996-07-03 | Ethicon Inc. | Stent. |
DE4303181A1 (en) | 1993-02-04 | 1994-08-11 | Angiomed Ag | Implantable catheter |
JP2703510B2 (en) * | 1993-12-28 | 1998-01-26 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Expandable stent and method of manufacturing the same |
US5609627A (en) * | 1994-02-09 | 1997-03-11 | Boston Scientific Technology, Inc. | Method for delivering a bifurcated endoluminal prosthesis |
US5643312A (en) | 1994-02-25 | 1997-07-01 | Fischell Robert | Stent having a multiplicity of closed circular structures |
US5449373A (en) | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
US5800521A (en) | 1994-11-09 | 1998-09-01 | Endotex Interventional Systems, Inc. | Prosthetic graft and method for aneurysm repair |
WO1996021404A1 (en) | 1995-01-14 | 1996-07-18 | Prograft, Medical, Inc. | Kink-resistant stent-graft |
US5755770A (en) | 1995-01-31 | 1998-05-26 | Boston Scientific Corporatiion | Endovascular aortic graft |
DE69637527D1 (en) | 1995-03-01 | 2008-06-26 | Boston Scient Scimed Inc | Longitudinally flexible and expandable stent |
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US6896696B2 (en) | 1998-11-20 | 2005-05-24 | Scimed Life Systems, Inc. | Flexible and expandable stent |
US5591197A (en) | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
DK0734698T4 (en) | 1995-04-01 | 2006-07-03 | Variomed Ag | Stent for transluminal implantation in hollow organs |
IL123039A (en) | 1995-07-25 | 2002-02-10 | Medstent Inc | Expandible stent |
US5776161A (en) | 1995-10-16 | 1998-07-07 | Instent, Inc. | Medical stents, apparatus and method for making same |
AU7458596A (en) | 1995-10-20 | 1997-05-07 | Bandula Wijay | Vascular stent |
WO1997025937A1 (en) | 1996-01-18 | 1997-07-24 | Jang G David | Programmable variably flexible modular stents |
US5980553A (en) | 1996-12-20 | 1999-11-09 | Cordis Corporation | Axially flexible stent |
US5895406A (en) | 1996-01-26 | 1999-04-20 | Cordis Corporation | Axially flexible stent |
US5938682A (en) | 1996-01-26 | 1999-08-17 | Cordis Corporation | Axially flexible stent |
EP1477133B9 (en) | 1996-03-05 | 2007-11-21 | Evysio Medical Devices Ulc | Expandable stent |
CA2192520A1 (en) * | 1996-03-05 | 1997-09-05 | Ian M. Penn | Expandable stent and method for delivery of same |
US6334871B1 (en) | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
DE19614160A1 (en) * | 1996-04-10 | 1997-10-16 | Variomed Ag | Stent for transluminal implantation in hollow organs |
US5922021A (en) | 1996-04-26 | 1999-07-13 | Jang; G. David | Intravascular stent |
US6235053B1 (en) * | 1998-02-02 | 2001-05-22 | G. David Jang | Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors |
US6152957A (en) | 1996-04-26 | 2000-11-28 | Jang; G. David | Intravascular stent |
US6241760B1 (en) | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
WO1997040783A2 (en) | 1996-04-26 | 1997-11-06 | Jang G David | Intravascular stent |
US5735814A (en) | 1996-04-30 | 1998-04-07 | Medtronic, Inc. | Techniques of treating neurodegenerative disorders by brain infusion |
US5697971A (en) | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US5893363A (en) * | 1996-06-28 | 1999-04-13 | Sonosight, Inc. | Ultrasonic array transducer transceiver for a hand held ultrasonic diagnostic instrument |
US5722412A (en) * | 1996-06-28 | 1998-03-03 | Advanced Technology Laboratories, Inc. | Hand held ultrasonic diagnostic instrument |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US6123712A (en) | 1996-08-23 | 2000-09-26 | Scimed Life Systems, Inc. | Balloon catheter with stent securement means |
US5776183A (en) | 1996-08-23 | 1998-07-07 | Kanesaka; Nozomu | Expandable stent |
DE19634700A1 (en) | 1996-08-28 | 1998-03-05 | Bayer Ag | Process for the production of rigid polyurethane foams |
US5807404A (en) | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US5824046A (en) | 1996-09-27 | 1998-10-20 | Scimed Life Systems, Inc. | Covered stent |
US5772669A (en) | 1996-09-27 | 1998-06-30 | Scimed Life Systems, Inc. | Stent deployment catheter with retractable sheath |
US5755776A (en) | 1996-10-04 | 1998-05-26 | Al-Saadon; Khalid | Permanent expandable intraluminal tubular stent |
WO1998020810A1 (en) * | 1996-11-12 | 1998-05-22 | Medtronic, Inc. | Flexible, radially expansible luminal prostheses |
DE29701758U1 (en) | 1997-02-01 | 1997-03-27 | Jomed Implantate Gmbh | Radially expandable stent for implantation in a body vessel, particularly in the area of a vascular branch |
DE29702671U1 (en) | 1997-02-17 | 1997-04-10 | Jomed Implantate Gmbh | Stent |
AU6464298A (en) * | 1997-03-13 | 1998-09-29 | United States Surgical Corporation | Flexible tissue supporting device |
US5810872A (en) | 1997-03-14 | 1998-09-22 | Kanesaka; Nozomu | Flexible stent |
US5718713A (en) | 1997-04-10 | 1998-02-17 | Global Therapeutics, Inc. | Surgical stent having a streamlined contour |
FR2762777B1 (en) | 1997-05-05 | 1999-10-22 | Patrick Sabaria | VASCULAR AND CORONARY EXTENDERS, USUALLY DESIGNATED UNDER THE NAME OF "STENT" |
US5741327A (en) | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
DE29708689U1 (en) | 1997-05-15 | 1997-07-17 | Jomed Implantate Gmbh | Coronary stent |
DE29708879U1 (en) | 1997-05-20 | 1997-07-31 | Jomed Implantate Gmbh | Coronary stent |
US5836966A (en) | 1997-05-22 | 1998-11-17 | Scimed Life Systems, Inc. | Variable expansion force stent |
US5913895A (en) * | 1997-06-02 | 1999-06-22 | Isostent, Inc. | Intravascular stent with enhanced rigidity strut members |
DE19834956B9 (en) | 1997-08-01 | 2005-10-20 | Eckhard Alt | Supporting prosthesis (stent) |
US5824059A (en) | 1997-08-05 | 1998-10-20 | Wijay; Bandula | Flexible stent |
DE29716476U1 (en) | 1997-09-13 | 1997-12-18 | Convent Gerd | Stenosis treatment stent |
US5948016A (en) | 1997-09-25 | 1999-09-07 | Jang; G. David | Intravascular stent with non-parallel slots |
US6129755A (en) | 1998-01-09 | 2000-10-10 | Nitinol Development Corporation | Intravascular stent having an improved strut configuration |
US6200334B1 (en) | 1998-02-03 | 2001-03-13 | G. David Jang | Tubular stent consists of non-parallel expansion struts and contralaterally attached diagonal connectors |
US6113627A (en) | 1998-02-03 | 2000-09-05 | Jang; G. David | Tubular stent consists of horizontal expansion struts and contralaterally attached diagonal-connectors |
WO1999039660A1 (en) * | 1998-02-03 | 1999-08-12 | B. Braun Celsa | Prosthesis with undulating longitudinal braces |
WO1999040876A2 (en) * | 1998-02-17 | 1999-08-19 | Jang G David | Tubular stent consists of chevron-shape expansion struts and ipsilaterally attached m-frame connectors |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6179868B1 (en) * | 1998-03-27 | 2001-01-30 | Janet Burpee | Stent with reduced shortening |
US5911754A (en) | 1998-07-24 | 1999-06-15 | Uni-Cath Inc. | Flexible stent with effective strut and connector patterns |
US6120522A (en) | 1998-08-27 | 2000-09-19 | Scimed Life Systems, Inc. | Self-expanding stent delivery catheter |
US20020019660A1 (en) * | 1998-09-05 | 2002-02-14 | Marc Gianotti | Methods and apparatus for a curved stent |
US6755856B2 (en) * | 1998-09-05 | 2004-06-29 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
US6682554B2 (en) * | 1998-09-05 | 2004-01-27 | Jomed Gmbh | Methods and apparatus for a stent having an expandable web structure |
DE19840645A1 (en) | 1998-09-05 | 2000-03-09 | Jomed Implantate Gmbh | Stent |
JP2000084090A (en) * | 1998-09-09 | 2000-03-28 | Kawasumi Lab Inc | Stent |
DE29816878U1 (en) | 1998-09-21 | 1998-12-24 | Schmitz Rode Thomas Dipl Ing D | Helix stent that can be manufactured using the cutting process |
US8092514B1 (en) | 1998-11-16 | 2012-01-10 | Boston Scientific Scimed, Inc. | Stretchable anti-buckling coiled-sheet stent |
ATE534353T1 (en) * | 1998-11-20 | 2011-12-15 | Boston Scient Ltd | FLEXIBLE LENGTH-EXTENSIBLE STENT |
EP1152710A1 (en) | 1999-01-22 | 2001-11-14 | Khalid Al-Saadon | Expandable intravascular tubular stents |
FR2793673B1 (en) | 1999-05-18 | 2001-10-12 | Jean Marie Lefebvre | TUBULAR STENT TYPE WITH LOW CRUSHING RESISTANCE |
EP1194079B1 (en) | 1999-07-02 | 2005-06-01 | Endotex Interventional Systems, Inc. | Flexible, stretchable coiled-sheet stent |
US20010047200A1 (en) | 1999-10-13 | 2001-11-29 | Raymond Sun | Non-foreshortening intraluminal prosthesis |
US6331189B1 (en) | 1999-10-18 | 2001-12-18 | Medtronic, Inc. | Flexible medical stent |
DE19952295A1 (en) | 1999-10-29 | 2001-05-23 | Angiomed Ag | Method of making a stent |
US6723119B2 (en) | 2000-03-01 | 2004-04-20 | Medinol Ltd. | Longitudinally flexible stent |
SG86458A1 (en) * | 2000-03-01 | 2002-02-19 | Medinol Ltd | Longitudinally flexible stent |
JP3654627B2 (en) * | 2000-04-20 | 2005-06-02 | 川澄化学工業株式会社 | Stent |
US6352552B1 (en) * | 2000-05-02 | 2002-03-05 | Scion Cardio-Vascular, Inc. | Stent |
GB0019535D0 (en) * | 2000-08-10 | 2000-09-27 | Koninkl Philips Electronics Nv | Two-terminal switch circuit and voltage threshold responsive circuit component |
ATE384486T1 (en) * | 2000-09-22 | 2008-02-15 | Boston Scient Ltd | FLEXIBLE AND EXPANDABLE STENT |
US20020116049A1 (en) | 2000-09-22 | 2002-08-22 | Scimed Life Systems, Inc. | Stent |
WO2002028319A2 (en) | 2000-10-05 | 2002-04-11 | Boston Scientific Limited | Stent delivery system with membrane |
US6679911B2 (en) * | 2001-03-01 | 2004-01-20 | Cordis Corporation | Flexible stent |
-
2002
- 2002-03-28 US US10/063,179 patent/US8070792B2/en not_active Expired - Fee Related
-
2003
- 2003-03-27 EP EP08020796A patent/EP2044908A1/en not_active Ceased
- 2003-03-27 AT AT03714463T patent/ATE337755T1/en not_active IP Right Cessation
- 2003-03-27 CA CA2446358A patent/CA2446358C/en not_active Expired - Fee Related
- 2003-03-27 BR BR0303669-3A patent/BR0303669A/en not_active IP Right Cessation
- 2003-03-27 KR KR10-2003-7015573A patent/KR20040104298A/en not_active Application Discontinuation
- 2003-03-27 JP JP2003579700A patent/JP2005521472A/en active Pending
- 2003-03-27 MX MXPA03010848A patent/MXPA03010848A/en not_active Application Discontinuation
- 2003-03-27 AT AT06016281T patent/ATE415919T1/en not_active IP Right Cessation
- 2003-03-27 DE DE60307976T patent/DE60307976T2/en not_active Expired - Lifetime
- 2003-03-27 EP EP06016281A patent/EP1719479B1/en not_active Expired - Lifetime
- 2003-03-27 DE DE60325118T patent/DE60325118D1/en not_active Expired - Lifetime
- 2003-03-27 IL IL15883402A patent/IL158834A0/en unknown
- 2003-03-27 WO PCT/US2003/009716 patent/WO2003082154A2/en active IP Right Grant
- 2003-03-27 CN CNA038003120A patent/CN1545400A/en active Pending
- 2003-03-27 AU AU2003218461A patent/AU2003218461A1/en not_active Abandoned
- 2003-03-27 EP EP03714463A patent/EP1437985B1/en not_active Expired - Lifetime
-
2009
- 2009-01-07 JP JP2009001821A patent/JP4750189B2/en not_active Expired - Fee Related
- 2009-09-14 JP JP2009211968A patent/JP4906899B2/en not_active Expired - Fee Related
-
2011
- 2011-09-23 US US13/243,379 patent/US9827120B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20020095208A1 (en) | 2002-07-18 |
JP4906899B2 (en) | 2012-03-28 |
MXPA03010848A (en) | 2004-11-22 |
US8070792B2 (en) | 2011-12-06 |
US9827120B2 (en) | 2017-11-28 |
JP2005521472A (en) | 2005-07-21 |
DE60307976T2 (en) | 2006-12-21 |
JP2009066452A (en) | 2009-04-02 |
AU2003218461A1 (en) | 2003-10-13 |
BR0303669A (en) | 2004-04-20 |
CA2446358A1 (en) | 2003-10-09 |
ATE415919T1 (en) | 2008-12-15 |
EP1719479A2 (en) | 2006-11-08 |
ATE337755T1 (en) | 2006-09-15 |
EP1719479A3 (en) | 2006-11-15 |
EP1719479B1 (en) | 2008-12-03 |
DE60325118D1 (en) | 2009-01-15 |
EP2044908A1 (en) | 2009-04-08 |
JP4750189B2 (en) | 2011-08-17 |
KR20040104298A (en) | 2004-12-10 |
EP1437985B1 (en) | 2006-08-30 |
IL158834A0 (en) | 2004-05-12 |
DE60307976D1 (en) | 2006-10-12 |
EP1437985A2 (en) | 2004-07-21 |
WO2003082154A3 (en) | 2004-02-19 |
WO2003082154A2 (en) | 2003-10-09 |
JP2009291641A (en) | 2009-12-17 |
US20120016462A1 (en) | 2012-01-19 |
CN1545400A (en) | 2004-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2446358C (en) | Improved stent | |
AU2003235619B2 (en) | Stent | |
US7635384B2 (en) | Varying circumferential spanned connectors in a stent | |
CA2472693C (en) | Stent with wishbone connectors and serpentine bands | |
EP1515663B1 (en) | Stent with polar radiopaque marker | |
EP1572035B1 (en) | Flexible stent with improved axial strength | |
US7722660B2 (en) | Segmented spine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140327 |